Citations

Citations to this article as recorded by  

• Attenuated adiponectin, omentin, increased interleukin-6 and tumor necrosis factor-alpha levels with altered cognition and depression in non-Hodgkin lymphoma patients: A case-control study
  Meghavi Kathpalia, Pinki Mishra, Afsha Majid, Mohd. Ashif Khan, Anurag Sharma, Dinesh Bhurani, Nidhi
  Journal of Neuroimmunology.2024; 392: 578372.     CrossRef
• Quality of life and late therapy effects in pediatric non‐Hodgkin lymphoma survivors: Insights from a single‐institution study
  Azza Ayad, Reham Khedr, Asmaa Hamoda, Nahla Elnabarawy, Elhamy Rifky, Tamer Diab, Eman El Desouky, Leslie Lehmann, Alaa Elhaddad
  Pediatric Blood & Cancer.2024;[Epub]     CrossRef
• Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
  Sohee Park, Ju Hwan Kim, Songhee Kim, Jisu Kang, Seoyoung Moon, Seok Jin Kim, Ju-Young Shin
  Blood Cancer Journal.2023;[Epub]     CrossRef
• Factors associated with long-term functional and psychosocial outcomes in patients with non-Hodgkin lymphoma
  Bhasker Amatya, Michael Dickinson , Fary Khan
  Journal of Rehabilitation Medicine.2023; 55: jrm004816.     CrossRef
• Experiences of and preferences for self-management among low grade non-Hodgkin's lymphoma survivors: A qualitative interview study
  Nickola D. Pallin, Mairead O'Connor, Alannah Gannon, John Browne, Mary R. Cahill, Derville O'Shea
  European Journal of Oncology Nursing.2023; 66: 102378.     CrossRef
• Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study
  Stephane Kroudia Wasse, Morgane Mounier, Emerline Assogba, Cédric Rossi, Johan Adnet, Sophie Gauthier, Stephanie Girard, Kueshivi Midodji Atsou, Tienhan Sandrine Dabakuyo-Yonli, Marc Maynadie
  Cancers.2023; 15(15): 3885.     CrossRef
• Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study
  Leo I. Gordon, Fei Fei Liu, Julia Braverman, Daanish Hoda, Nilanjan Ghosh, Mehdi Hamadani, Gerhard C. Hildebrandt, Lily Peng, Shien Guo, Ling Shi, Alison Sehgal
  Haematologica.2023; 109(3): 857.     CrossRef
• Quality of life and fear of cancer recurrence in patients and survivors of non-Hodgkin lymphoma
  Susan Ellis, Rhonda F. Brown, Einar B. Thorsteinsson, Kenneth I. Pakenham, Colin Perrott
  Psychology, Health & Medicine.2022; 27(8): 1649.     CrossRef
• Pre‐treatment health‐related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA‐BERIT) experience
  Åsa Lindberg, Christian Winther Eskelund, Alexandra Albertsson‐Lindblad, Arne Kolstad, Anna Laurell, Riikka Räty, Kirsten Grønbæk, Christian Hartmann Geisler, Mats Jerkeman
  Hematological Oncology.2022; 40(1): 23.     CrossRef
• Treatment Outcomes and Its Associated Factors Among Adult Patients with Selected Solid Malignancies at Kenyatta National Hospital: A Hospital-Based Prospective Cohort Study
  Amsalu Degu, Ermias Mergia Terefe, Eliab Seroney Some, Gobezie T Tegegne
  Cancer Management and Research.2022; Volume 14: 1525.     CrossRef
• Living with or beyond lymphoma: A rapid review of the unmet needs of lymphoma survivors
  Vanessa Boland, Amanda Drury, Greg Sheaf, Anne‐Marie Brady
  Psycho-Oncology.2022; 31(7): 1076.     CrossRef
• The forgotten survivor: A comprehensive review on Non‐Hodgkin lymphoma survivorship
  Mohamad S. Alabdaljabar, Urshila Durani, Carrie A. Thompson, Louis S. Constine, Shahrukh K. Hashmi
  American Journal of Hematology.2022; 97(12): 1627.     CrossRef
• Unmet Needs and Quality of Life of Colorectal Cancer Survivors Immediately after Treatment Ends and 5 Years
  Hyedan Kim, Eunsook Wi, Mi Hwa Jang, Sung Hee Jo, Hye Kyung Kim
  Asian Oncology Nursing.2022; 22(3): 145.     CrossRef
• Trajectories of symptom severity predicts quality of life change in newly diagnosis lymphoma survivors: An initial study
  Chih‐Jung Wu, Yu‐Chi Chen, Li‐Yuan Bai, Tzeon‐Jye Chiou, Kuan‐Chia Lin, Ya‐Jung Wang
  European Journal of Cancer Care.2022;[Epub]     CrossRef
• Exploring health-related quality of life among non-Hodgkin’s lymphoma survivors after completion of primary treatment: a cross-sectional study in Thailand
  Pichitra Lekdamrongkul, Kanaungnit Pongthavornkamol, Alex Molassiotis, Aurawamon Sriyuktasuth, Noppadol Siritanaratkul, Natkamol Chansatitporn
  Supportive Care in Cancer.2021; 29(11): 6511.     CrossRef
• Experiences of patients with lung cancer receiving concurrent chemo-radiotherapy
  Choi Eunsook, Park Sunhee
  Clinical Journal of Nursing Care and Practice.2021; 5(1): 015.     CrossRef
• Coping strategies among patients with malignant lymphoma– a qualitative study from the perspectives of Swedish patients
  Stinne Glasdam, Charlotta Bjerström, Cecilia Engberg de Carvalho
  European Journal of Oncology Nursing.2020; 44: 101693.     CrossRef
• Impact of fear of cancer recurrence on survival among lymphoma patients
  Seok Jin Kim, Danbee Kang, Im Ryung Kim, Sang Eun Yoon, Won Seog Kim, Phyllis N. Butow, Eliseo Guallar, Juhee Cho
  Psycho-Oncology.2020; 29(2): 364.     CrossRef
• Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma
  Andrew Davies, Peter Trask, Judit Demeter, Axel Florschütz, Mathias Hänel, Tomohiro Kinoshita, Ruth Pettengell, Hang Quach, Stephen Robinson, Shalal Sadullah, Juan-Manuel Sancho, Miklos Udvardy, Mathias Witzens-Harig, Andrea Knapp, Wenxin Liu
  Annals of Hematology.2020; 99(12): 2837.     CrossRef
• Quality of Life and Impact of Cancer: Differences in Rural and Nonrural Non‐Hodgkin's Lymphoma Survivors
  Devon Noonan, Matthew LeBlanc, Cherie Conley, Habtamu Benecha, Ashley Leak‐Bryant, Kellen Peter, Sheryl Zimmerman, Deborah Mayer, Sophia Smith
  The Journal of Rural Health.2020; 36(4): 536.     CrossRef
• Semen quality in non-Hodgkin lymphoma survivors: a monocentric retrospective study
  Francesco Pallotti, Marianna Pelloni, Fabiana Faja, Silvia Di Chiano, Alice Di Rocco, Andrea Lenzi, Francesco Lombardo, Donatella Paoli
  Human Reproduction.2020;[Epub]     CrossRef
• Prognostic Value of Post-diagnosis Health-Related Quality of Life for Overall Survival in Breast Cancer: Findings from a 10-Year Prospective Cohort in Korea
  Tran Thi Xuan Mai, Jin Hyuk Choi, Myung Kyung Lee, Yoon Jung Chang, So-Youn Jung, Hyunsoon Cho, Eun Sook Lee
  Cancer Research and Treatment.2019; 51(4): 1600.     CrossRef

Citations

Citations to this article as recorded by  

• The emerging role of fatty acid binding protein 7 (FABP7) in cancers
  William George Warren, Myles Osborn, Andrew Yates, Saoirse E. O’Sullivan
  Drug Discovery Today.2024; 29(5): 103980.     CrossRef
• Pulmonary adenoid cystic carcinoma: molecular characteristics and literature review
  Zhixin Chen, Jiapeng Jiang, Ying Fan, Hongyang Lu
  Diagnostic Pathology.2023;[Epub]     CrossRef
• Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma
  Liubing Hou, Huandi Zhou, Yanqiang Wang, Junling Liu, Dongdong Zhang, Yuehong Li, Xiaoying Xue, Zhijie Xu
  Disease Markers.2022; 2022: 1.     CrossRef
• Clinical Utility of Fine-Needle Aspiration Cytology for Adenoid Cystic Carcinoma of the Trachea with Thyroid Invasion: A Case Report
  Tomoo Jikuzono, Shigekazu Suzuki, Osamu Ishibashi, Shoko Kure, Atsuko Sakanushi, Munenaga Nakamizo, Masashi Kawamoto, Ryuji Ohashi, Tetsu Yamada, Iwao Sugitani
  Journal of Nippon Medical School.2022; 89(4): 460.     CrossRef
• Identification of recurrent variants implicated in disease in bicuspid aortic valve patients through whole-exome sequencing
  Shasha Chen, Qinchun Jin, Shiqiang Hou, Mingfei Li, Yuan Zhang, Lihua Guan, Wenzhi Pan, Junbo Ge, Daxin Zhou
  Human Genomics.2022;[Epub]     CrossRef
• A Case of Solid Variant of Adenoid Cystic Carcinoma from Trachea: A Case Report and Review of Literature
  Feng Gao, Lijuan Zang, Jin He, Weiqing Xu
  OncoTargets and Therapy.2021; Volume 14: 1997.     CrossRef
• Role of FABP7 in tumor cell signaling
  Yoshiteru Kagawa, Banlanjo A. Umaru, Islam Ariful, Subrata Kumar Shil, Hirofumi Miyazaki, Yui Yamamoto, Masaki Ogata, Yuji Owada
  Advances in Biological Regulation.2019; 71: 206.     CrossRef
• Role of fatty acid binding proteins (FABPs) in cancer development and progression
  Iain H. McKillop, Cara A. Girardi, Kyle J. Thompson
  Cellular Signalling.2019; 62: 109336.     CrossRef
• Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma
  Julia Thierauf, Nisha Ramamurthy, Vickie Y. Jo, Hayley Robinson, Ryan P. Frazier, Jonathan Gonzalez, Maciej Pacula, Enrique Dominguez Meneses, Vania Nose, Valentina Nardi, Dora Dias-Santagata, Long P. Le, Derrick T. Lin, William C. Faquin, Lori J. Wirth,
  The Oncologist.2019; 24(10): 1356.     CrossRef
• FABP7 promotes cell proliferation and survival in colon cancer through MEK/ERK signaling pathway
  Ran Ma, Lan Wang, Fang Yuan, Shaoxuan Wang, Yingping Liu, Tingting Fan, Fulai Wang
  Biomedicine & Pharmacotherapy.2018; 108: 119.     CrossRef

Citations

Citations to this article as recorded by  

• Identifying the factors affecting financial toxicity status in patients with middle and advanced colorectal cancer: a cross-sectional study
  Xiaofang He, Jie Chen, Lin Zhang, Qiuping Li, Xiaoli Zhu, Jie Zhao, Ying Chen
  Frontiers in Public Health.2024;[Epub]     CrossRef
• Individual and joint effect of socioeconomic status and lifestyle factors on cancer in Korea
  Chi Lan Tran, Kui Son Choi, Sun‐Young Kim, Jin‐Kyoung Oh
  Cancer Medicine.2023; 12(16): 17389.     CrossRef
• Financial hardship in families of children or adolescents with cancer: a systematic literature review
  Julie Ritter, Savannah Allen, Phillip D Cohen, Andrés Felipe Fajardo, Kelsey Marx, Patrícia Loggetto, Carmen Auste, Hedley Lewis, Karla Emília de Sá Rodrigues, Sharmeen Hussain, Ayomide Omotola, Nancy S Bolous, Harsha Thirumurthy, Beverley M Essue, Eva St
  The Lancet Oncology.2023; 24(9): e364.     CrossRef
• Trends in medical care utilization in patients with cancer: An analysis of real‐world data in a tertiary hospital in Korea, 2014–2019
  Jung‐Hyun Won, Tae Kyu Chung, Joochul Lee, Sangwon Yoon, Yoomin Jeon, Howard Lee
  Cancer Medicine.2023; 12(22): 21022.     CrossRef
• Impact of objective financial burden and subjective financial distress on spiritual well-being and quality of life among working-age cancer survivors
  Danbee Kang, Ka Ryeong Bae, Jihyun Lim, Nayeon Kim, Sungkeun Shim, Sun Seog Kweon, Hwa Jeong Seo, Juhee Cho
  Supportive Care in Cancer.2022; 30(6): 4917.     CrossRef
• The influence of cross-regional medical treatment on total medical expenses, medical insurance payments, and out-of-pocket expenses of patients with malignant tumors in Chinese low-income areas
  Bokai Zhang, Haixin Wang, Hongyu Zhang, Guomei Tian, Ting Zhang, Qi Shi, Jian Liu, Jinpeng Xu, Jingchu Liu, Qunhong Wu, Zheng Kang
  Cost Effectiveness and Resource Allocation.2022;[Epub]     CrossRef
• Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems
  Divya A. Parikh, Meera Ragavan, Ritika Dutta, Jeffrey Garnet Edwards, James Dickerson, Debeshi Maitra, Sangeeta Aggarwal, Fa-Chyi Lee, Manali I. Patel
  JCO Oncology Practice.2021; 17(10): e1450.     CrossRef
• Burden of Treatment among Elderly Patients with Cancer: A Scoping Review
  Adem Sav, Sara S. McMillan, Adeola Akosile
  Healthcare.2021; 9(5): 612.     CrossRef
• Symptom experiences and health‐related quality of life among non‐small cell lung cancer patients participating in clinical trials
  Kyunghwa Lee, Eui Geum Oh, Sanghee Kim, Sang‐We Kim
  Journal of Clinical Nursing.2019; 28(11-12): 2111.     CrossRef
• The Incidences and Characteristics of Various Cancers in Patients on Dialysis: a Korean Nationwide Study
  Soon Kil Kwon, Joung-Ho Han, Hye-Young Kim, Gilwon Kang, Minseok Kang, Yeonkook J. Kim, Jinsoo Min
  Journal of Korean Medical Science.2019;[Epub]     CrossRef
• Higher Age Puts Lung Cancer Patients at Risk for Not Receiving Anti-cancer Treatment
  Won-Il Choi, Jiah Choi, Mi-Ae Kim, Gyumin Lee, Jihyeon Jeong, Choong Won Lee
  Cancer Research and Treatment.2019; 51(3): 1241.     CrossRef

Citations

Citations to this article as recorded by  

• Radiomics and Deep Learning in Nasopharyngeal Carcinoma: A Review
  Zipei Wang, Mengjie Fang, Jie Zhang, Linquan Tang, Lianzhen Zhong, Hailin Li, Runnan Cao, Xun Zhao, Shengyuan Liu, Ruofan Zhang, Xuebin Xie, Haiqiang Mai, Sufang Qiu, Jie Tian, Di Dong
  IEEE Reviews in Biomedical Engineering.2024; 17: 118.     CrossRef
• Novel prediction model combining PET/CT metabolic parameters, inflammation markers, and TNM stage: prospects for personalizing prognosis in nasopharyngeal carcinoma
  Huan Liang, Weilin Tan, Jie Wang, Mengdan Li, Hua Pang, Xiaohui Wang, Lu Yang, Xingguo Jing
  Annals of Nuclear Medicine.2024; 38(10): 802.     CrossRef
• Can Epstein–Barr virus‐deoxyribonucleic acid load after induction chemotherapy combined with American Joint Committee on Cancer stage determine the chemotherapy intensity of locally advanced nasopharyngeal carcinoma?
  Qun Zhang, Zhen‐Wei Peng, Zhuo‐Sheng Gu, Yan Wang, Fang He, Wen‐Bin Zhao, Wei Luo, Yong‐Yu Mei
  Cancer Medicine.2023; 12(1): 223.     CrossRef
• Prioritizing sufficient dose to gross tumor volume over normal tissue sparing in intensity‐modulated radiotherapy treatment of T4 nasopharyngeal carcinoma
  Yanyan Chen, Quxia Zhang, Tianzhu Lu, Cairong Hu, Jingfeng Zong, Yun Xu, Wei Zheng, Lisha Chen, Senan Lin, Sufang Qiu, Luying Xu, Jianji Pan, Qiaojuan Guo, Shaojun Lin
  Head & Neck.2023; 45(5): 1130.     CrossRef
• Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma
  Bingxin Gu, Mingyuan Meng, Mingzhen Xu, David Dagan Feng, Lei Bi, Jinman Kim, Shaoli Song
  European Journal of Nuclear Medicine and Molecular Imaging.2023; 50(13): 3996.     CrossRef
• Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma
  Shan-Shan Guo, Yan-Zhou Chen, Li-Ting Liu, Rong-Ping Liu, Yu-Jing Liang, Dong-Xiang Wen, Jing Jin, Lin-Quan Tang, Hai-Qiang Mai, Qiu-Yan Chen
  BMC Cancer.2022;[Epub]     CrossRef
• DeepMTS: Deep Multi-Task Learning for Survival Prediction in Patients With Advanced Nasopharyngeal Carcinoma Using Pretreatment PET/CT
  Mingyuan Meng, Bingxin Gu, Lei Bi, Shaoli Song, David Dagan Feng, Jinman Kim
  IEEE Journal of Biomedical and Health Informatics.2022; 26(9): 4497.     CrossRef
• Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy
  Cui-Dai Zhang, Mei Li, Ying-Ji Hong, Ze-Man Cai, Kai-Chun Huang, Zhi-Xiong Lin, Zhi-Ning Yang
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area
  Ji-Jin Yao, Li Lin, Tian-Sheng Gao, Wang-Jian Zhang, Wayne R. Lawrence, Jun Ma, Ying Sun
  Cancer Research and Treatment.2021; 53(3): 657.     CrossRef
• Nomogram predict relapse-free survival of patients with thymic epithelial tumors after surgery
  Yang-Yu Huang, Lei-Lei Wu, Xuan Liu, Shen-Hua Liang, Guo-Wei Ma
  BMC Cancer.2021;[Epub]     CrossRef
• Establishment and validation of a nomogram with intratumoral heterogeneity derived from 18F-FDG PET/CT for predicting individual conditional risk of 5-year recurrence before initial treatment of nasopharyngeal carcinoma
  Bingxin Gu, Jianping Zhang, Guang Ma, Shaoli Song, Liqun Shi, Yingjian Zhang, Zhongyi Yang
  BMC Cancer.2020;[Epub]     CrossRef

• Prognostic Nomogram for Patients with Radical Surgery for Non-Metastatic Colorectal Cancer Incorporating Hematological Biomarkers and Clinical Characteristics

  
  Peiyun Long, Youya Zang, Huan Wang, Xiumei Liang, Xuekun Xie, Zhiwei Han, Dongyi Lin, Zongyu Wang, Shan Huang, Chuang Chen
  OncoTargets and Therapy.2020; Volume 13: 2093.     CrossRef
• Impact of Paranasal Sinus Invasion on Oncologic and Dosimetric Outcomes in Nasopharyngeal Carcinoma Following Intensity-Modulated Radiation Therapy—Implications for Risk Stratification and Planning Optimization
  Xin Zhou, Xiayun He, Fen Xue, Xiaomin Ou, Chaosu Hu
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients
  Nicola Alessandro Iacovelli, Alessandro Cicchetti, Anna Cavallo, Salvatore Alfieri, Laura Locati, Eliana Ivaldi, Rossana Ingargiola, Domenico A. Romanello, Paolo Bossi, Stefano Cavalieri, Chiara Tenconi, Silvia Meroni, Giuseppina Calareso, Marco Guzzo, Ce
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma
  Lu-Lu Zhang, Fei Xu, Di Song, Meng-Yao Huang, Yong-Shi Huang, Qi-Ling Deng, Yi-Yang Li, Jian-Yong Shao
  JAMA Network Open.2020; 3(12): e2029882.     CrossRef
• Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups
  En-Hong Zhuo, Wei-Jing Zhang, Hao-Jiang Li, Guo-Yi Zhang, Bing-Zhong Jing, Jian Zhou, Chun-Yan Cui, Ming-Yuan Chen, Ying Sun, Li-Zhi Liu, Hong-Min Cai
  European Radiology.2019; 29(10): 5590.     CrossRef
• Impact of paranasal sinus invasion on advanced nasopharyngeal carcinoma treated with intensity‐modulated radiation therapy: the validity of advanced T stage of AJCC/UICC eighth edition staging system
  Ying Wang, Jie Zhao, Yajie Zhao, Zhen Yang, Mingjun Lei, Zhanzhan Li, Rui Wei, Dengming Chen, Yuxiang He, Liangfang Shen
  Cancer Medicine.2018; 7(7): 2826.     CrossRef

Citations

Citations to this article as recorded by  

• Factors influencing the intention for lung cancer screening in high-risk populations for lung cancer
  Mi-Kyoung Cho, Yoon Hee Cho
  Asia-Pacific Journal of Oncology Nursing.2024; 11(1): 100332.     CrossRef
• Screening behaviors of high-risk individuals for lung cancer: A cross-sectional study
  Yu-An Lin, Xiujing Lin, Yonglin Li, Fangfang Wang, Rachel Arbing, Weiti Chen, Feifei Huang
  Asia-Pacific Journal of Oncology Nursing.2024; 11(4): 100402.     CrossRef
• Speed and efficiency: evaluating pulmonary nodule detection with AI-enhanced 3D gradient echo imaging
  Sebastian Ziegelmayer, Alexander W. Marka, Maximilian Strenzke, Tristan Lemke, Hannah Rosenkranz, Bernadette Scherer, Thomas Huber, Kilian Weiss, Marcus R. Makowski, Dimitrios C. Karampinos, Markus Graf, Joshua Gawlitza
  European Radiology.2024;[Epub]     CrossRef
• A Health Inequity: Associations Between Cigarette Smoking Status and Mammogram Screening Among Women of Color
  Danielle H Llaneza, Hanjoe Kim, Virmarie Correa-Fernández
  Nicotine & Tobacco Research.2023; 25(1): 66.     CrossRef
• Motivation, acceptability and attitudes toward lung cancer screening among persons who attend a tobacco cessation program: A multicenter survey in Italy
  Olivera Djuric, Paolo Giorgi Rossi, Elena Camelia Ivanciu, Salvatore Cardellicchio, Chiara Cresci, Laura Carozzi, Francesco Pistelli, Valentina Bessi, Patrizia Gai, Valentina Galli, Giacomo Lavacchini, Claudia Bricci, Giuseppe Gorini, Sandra Bosi, Eugenio
  Preventive Medicine Reports.2023; 35: 102272.     CrossRef
• Temporal Evolution and Associated Factors of Adherence to Mammography Screening among Women in Spain: Results from Two National Health Surveys (2017–2020)
  Silvia Portero de la Cruz, Luis M. Béjar, Jesús Cebrino
  Healthcare.2023; 11(22): 2934.     CrossRef
• Cross-Cultural Adaptation of Lung Cancer Screening Health Belief Scale in Chinese Americans: A Methodological Study
  Fang Lei, Wei-Ti Chen, Mary-Lynn Brecht, Zuo-Feng Zhang, Yuhe Hu, Tuzhen Xu, Siqian Wang, Eunice Lee
  Journal of Nursing Measurement.2023; 31(4): 489.     CrossRef
• Adaptation and validation of the Chinese version of the lung cancer screening health belief scales
  Yu-an Lin, Lisa Carter-Harris, Jia-ni Yang, Xiu jing Lin, Fei fei Huang
  BMC Public Health.2022;[Epub]     CrossRef
• Barriers and facilitators to uptake of lung cancer screening: A mixed methods systematic review
  Yu-an Lin, Yu ting Hong, Xiu jing Lin, Jia ling Lin, Hui min Xiao, Fei fei Huang
  Lung Cancer.2022; 172: 9.     CrossRef
• Promoting Community Awareness of Lung Cancer Screening Among Disparate Populations
  Lovoria B. Williams, Stephen W. Looney, Thomas Joshua, Amber McCall, Martha S. Tingen
  Cancer Nursing.2021; 44(2): 89.     CrossRef
• Evaluating Knowledge, Attitudes, and Beliefs About Lung Cancer Screening Using Crowdsourcing
  John Monu, Matthew Triplette, Douglas E. Wood, Erika M. Wolff, Danielle C. Lavallee, David R. Flum, Farhood Farjah
  Chest.2020; 158(1): 386.     CrossRef
• Understanding the Associations between Smoking-Related Risk Perception, Interest in Quitting Smoking, and Interest in Lung Cancer Screening among Homeless Adult Smokers
  Pooja Agrawal, Matthew Taing, Tzu-An Chen, Sean Reuven, Michael Businelle, Darla Kendzor, Eric Bernicker, Lorraine Reitzel
  International Journal of Environmental Research and Public Health.2020; 17(23): 8817.     CrossRef

Citations

Citations to this article as recorded by  

• Radiographic features predictive of recurrence and survival after surgical resection of perihilar cholangiocarcinoma
  Julaluck Promsorn, Panjaporn Naknan, Aumkhae Sookprasert, Kosin Wirasorn, Jarin Chindaprasirt, Attapol Titapun, Piyapharom Intarawichian, Mukesh Harisinghani
  Heliyon.2024; 10(7): e28805.     CrossRef
• Practice guidelines for managing extrahepatic biliary tract cancers
  Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bohyun Kim, Seong-Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji Hae Nahm, Won Suk Park, Eunkyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong
  Annals of Hepato-Biliary-Pancreatic Surgery.2024; 28(2): 161.     CrossRef
• Influence of Perineural (Pn), Lymphangio (L) and Vascular (V) Invasion on Survival after Resection of Perihilar Cholangiocarcinoma
  Rabea Margies, Lisa-Katharina Gröger, Beate K. Straub, Fabian Bartsch, Hauke Lang
  Cancers.2024; 16(20): 3463.     CrossRef
• Liver transplantation for unresectable Klatskin tumor: experience of two centers, first distant results
  D. A. Granov, V. N. Zhuikov, I. I. Tileubergenov, A. V. Moiseenko, I. O. Rutkin, A. R. Sheraliev, A. A. Polikarpov, O. O. Rummo, A. E. Shcherba, I. P. Shturich, S. V. Korotkov, L. V. Kirkovsky, T. M. Chernishov
  Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery.2024; 29(3): 70.     CrossRef
• Molecular profiling and prognostic analysis in Chinese cholangiocarcinoma: an observational, retrospective single-center study
  Changkun Zhang, Xia You, Qin Zhang, Dong Wang
  Investigational New Drugs.2023;[Epub]     CrossRef
• Significance of dysplasia in bile duct resection margin in patients with extrahepatic cholangiocarcinoma: A retrospective analysis
  Jung Wan Choe, Hyo Jung Kim, Jae Seon Kim
  World Journal of Clinical Cases.2022; 10(10): 3078.     CrossRef
• Klatskin Tumor: A Survival Analysis According to Tumor Characteristics and Inflammatory Ratios
  Vlad-Ionuţ Nechita, Emil Moiş, Luminiţa Furcea, Mihaela-Ancuţa Nechita, Florin Graur
  Medicina.2022; 58(12): 1788.     CrossRef
• Impact of Remnant Carcinoma in Situ at the Ductal Stump on Long‐Term Outcomes in Patients with Distal Cholangiocarcinoma
  Koya Yasukawa, Akira Shimizu, Hiroaki Motoyama, Koji Kubota, Tsuyoshi Notake, Kentaro Fukushima, Tomohiko Ikehara, Hikaru Hayashi, Akira Kobayashi, Yuji Soejima
  World Journal of Surgery.2021; 45(1): 291.     CrossRef
• Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients
  Feiling Feng, Xiaobing Wu, Xiaoliang Shi, Qingxiang Gao, Yue Wu, Yong Yu, Qingbao Cheng, Bin Li, Bin Yi, Chen Liu, Qing Hao, Lin Zhang, Chunfang Gao, Xiaoqing Jiang
  International Journal of Clinical Oncology.2021; 26(4): 717.     CrossRef
• Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma
  Jong Woo Lee, Jae Hoon Lee, Yejong Park, Jaewoo Kwon, Woohyung Lee, Ki Byung Song, Dae Wook Hwang, Song Cheol Kim
  Journal of Clinical Medicine.2021; 10(7): 1345.     CrossRef
• Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System
  Jong Woo Lee, Jae Hoon Lee, Yejong Park, Woohyung Lee, Jaewoo Kwon, Ki Byung Song, Dae Wook Hwang, Song Cheol Kim
  Cancer Research and Treatment.2020; 52(3): 886.     CrossRef
• Comparative study of laparoscopic‐assisted and open total gastrectomy for Siewert Types II and III adenocarcinoma of the esophagogastric junction
  Jianchu Wang, Jin‐Cheng Wang, Bin Song, Xu‐Dong Dai, Xiao‐Yu Zhang
  Journal of Cellular Physiology.2019; 234(7): 11235.     CrossRef
• Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma
  Toshifumi Wakai, Jun Sakata, Tomohiro Katada, Yuki Hirose, Daiki Soma, Pankaj Prasoon, Kohei Miura, Takashi Kobayashi
  Annals of Gastroenterological Surgery.2018; 2(5): 359.     CrossRef

Citations

Citations to this article as recorded by  

• Cancer Risk Following Smoking Cessation in Korea
  Eunjung Park, Hee-Yeon Kang, Min Kyung Lim, Byungmi Kim, Jin-Kyoung Oh
  JAMA Network Open.2024; 7(2): e2354958.     CrossRef
• Impact of smoking reduction on lung cancer risk in patients with COPD who smoked fewer than 30 pack-years: a nationwide population-based cohort study
  Sun Hye Shin, Taeyun Kim, Hyunsoo Kim, Juhee Cho, Danbee Kang, Hye Yun Park
  Respiratory Research.2024;[Epub]     CrossRef
• Changes in smoking use and subsequent lung cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
  Daniela S Gutiérrez-Torres, Sungduk Kim, Demetrius Albanes, Stephanie J Weinstein, Maki Inoue-Choi, Paul S Albert, Neal D Freedman
  JNCI: Journal of the National Cancer Institute.2024; 116(6): 895.     CrossRef
• Global epidemiology of early‐onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019
  Pojsakorn Danpanichkul, Thanida Auttapracha, Siwanart Kongarin, Ben Ponvilawan, Daniel M. Simadibrata, Kwanjit Duangsonk, Supitchaya Jaruvattanadilok, Sakditad Saowapa, Kanokphong Suparan, Rashid N. Lui, Suthat Liangpunsakul, Michael B. Wallace, Karn Wija
  Journal of Gastroenterology and Hepatology.2024; 39(9): 1856.     CrossRef
• Smoking cessation rate and predictors of successful quitting in Jordan: A cross-sectional study
  Nuha W. Qasem, Batool H. Al-Omoush, Sami K. Altbeinat, Moutasem M. Al-Dlaijem, Reham I. Salahat, Samer A. Okour
  Medicine.2024; 103(27): e38708.     CrossRef
• Smoking-attributable Mortality in Korea, 2020: A Meta-analysis of 4 Databases
  Eunsil Cheon, Yeun Soo Yang, Suyoung Jo, Jieun Hwang, Keum Ji Jung, Sunmi Lee, Seong Yong Park, Kyoungin Na, Soyeon Kim, Sun Ha Jee, Sung-il Cho
  Journal of Preventive Medicine and Public Health.2024; 57(4): 327.     CrossRef
• Passive smoking and risk of pancreatic cancer: an updated systematic review and meta-analysis
  Xudong Wang, Zihan Wang, Xujie Wang
  PeerJ.2024; 12: e18017.     CrossRef
• Body mass index, waist circumference and cardiovascular diseases in transitional ages (40 and 66 years)
  Jung Eun Yoo, Kyungdo Han, Jin‐Hyung Jung, Yang‐Im Hur, Yang Hyun Kim, Eun Sook Kim, Jang Won Son, Eun‐Jung Rhee, Won‐Young Lee, Ga Eun Nam
  Journal of Cachexia, Sarcopenia and Muscle.2023; 14(1): 369.     CrossRef
• Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma
  Jing-Rong Jhuang, Po-Chun Chiu, Tung-Che Hsieh, Chung-Hsin Chen, Yeong-Shiau Pu, Wen-Chung Lee
  Frontiers in Public Health.2023;[Epub]     CrossRef
• Association between smoking and obstructive sleep apnea based on the STOP-Bang index
  Yun Seo Jang, Nataliya Nerobkova, Kyungduk Hurh, Eun-Cheol Park, Jaeyong Shin
  Scientific Reports.2023;[Epub]     CrossRef
• The effects of smoking habit change on the risk of depression–Analysis of data from the Korean National Health Insurance Service
  Ga Eun Kim, Min-ho Kim, Weon-Jeon Lim, Soo In Kim
  Journal of Affective Disorders.2022; 302: 293.     CrossRef
• Effect of smoking reduction, cessation, and resumption on cancer risk: A nationwide cohort study
  Jung Eun Yoo, Kyungdo Han, Dong Wook Shin, Wonyoung Jung, Dahye Kim, Cheol Min Lee, Hyuktae Kwon, Kyu‐Won Jung, Yun‐Mi Song
  Cancer.2022; 128(11): 2126.     CrossRef
• Psychosocial stress and cancer risk: a narrative review
  Ananyaa Mohan, Inge Huybrechts, Nathalie Michels
  European Journal of Cancer Prevention.2022; 31(6): 585.     CrossRef
• Smoking trajectory and cancer risk: A population-based cohort study
  Minh Luu, Minji Han, Tra Bui, Phuong Thao Tran, Min-Kyung Lim, Jin Oh
  Tobacco Induced Diseases.2022; 20(August): 1.     CrossRef
• Longitudinal Changes in Smoking Habits in Women and Subsequent Risk of Cancer
  Thi Xuan Mai Tran, Soyeoun Kim, Huiyeon Song, Boyoung Park
  American Journal of Preventive Medicine.2022; 63(6): 894.     CrossRef
• Health promotion: the essence of primary healthcare
  Sung Sunwoo
  Journal of the Korean Medical Association.2022; 65(12): 772.     CrossRef
• Cigarette Smoking Reduction and Health Risks: A Systematic Review and Meta-analysis
  Joanne T Chang, Gabriella M Anic, Brian L Rostron, Manju Tanwar, Cindy M Chang
  Nicotine & Tobacco Research.2021; 23(4): 635.     CrossRef
• Decreased Levels of Soluble CD44 in a High-Risk Population following a Smoking Cessation Program
  Drew H. Smith, Shahm Raslan, Isildinha M. Reis, Abdurrahman Al-Awady, Isabella Buitron, Melanie Perez, Huaping Liu, Jerri Halgowich, Claudia Gordon, Monica Webb Hooper, Noël C. Barengo, Elizabeth J. Franzmann
  International Journal of Environmental Research and Public Health.2021; 18(24): 13174.     CrossRef
• Exposure to oral bisphosphonates and risk of gastrointestinal cancer
  D. Choi, S. Choi, J. Chang, S. M. Park
  Osteoporosis International.2020; 31(4): 775.     CrossRef
• Smoking Cessation Improves the Symptoms and the Findings of Laryngeal Irritation
  A. Secil Kayalı Dinc, Melih Cayonu, Tijen Sengezer, M. Melih Sahin
  Ear, Nose & Throat Journal.2020; 99(2): 124.     CrossRef
• Association between Post-Diagnosis Particulate Matter Exposure among 5-Year Cancer Survivors and Cardiovascular Disease Risk in Three Metropolitan Areas from South Korea
  Seulggie Choi, Kyae Hyung Kim, Kyuwoong Kim, Jooyoung Chang, Sung Min Kim, Seong Rae Kim, Yoosun Cho, Gyeongsil Lee, Joung Sik Son, Sang Min Park
  International Journal of Environmental Research and Public Health.2020; 17(8): 2841.     CrossRef
• Cigarette Smoking Is Associated with Increased Risk of Malignant Gliomas: A Nationwide Population-Based Cohort Study
  Stephen Ahn, Kyung-Do Han, Yong-Moon Park, Jung Min Bae, Sang Uk Kim, Sin-Soo Jeun, Seung Ho Yang
  Cancers.2020; 12(5): 1343.     CrossRef
• The Association of Smoking Exposure at Home with Attempts to Quit Smoking and Cessation Success: A Survey of South Korean Adolescents Who Smoke
  Wonjeong Jeong, Yun Kyung Kim, Jae Hong Joo, Sung-In Jang, Eun-Cheol Park
  International Journal of Environmental Research and Public Health.2020; 17(11): 4129.     CrossRef
• Exploring smoking cessation behaviors of outpatients in outpatient clinics
  Ching-Yi Hsu, Hung-En Liao, Li-Chun Huang
  Medicine.2020; 99(27): e20971.     CrossRef
• UegWeek 2020 Poster Presentations
  
  United European Gastroenterology Journal.2020; 8(S8): 144.     CrossRef
• Assessing the lung cancer risk reduction potential of candidate modified risk tobacco products
  Julia Hoeng, Serge Maeder, Patrick Vanscheeuwijck, Manuel C. Peitsch
  Internal and Emergency Medicine.2019; 14(6): 821.     CrossRef
• Prevalence of tobacco related chronic diseases and its role in smoking cessation among smokers in a rural area of Shanghai, China: a cross sectional study
  Ruiping Wang, Yonggen Jiang, Chunxia Yao, Meiying Zhu, Qi Zhao, Limei Huang, Guimin Wang, Ying Guan, Engelgau Michael, Genming Zhao
  BMC Public Health.2019;[Epub]     CrossRef
• Relationships between smoking duration, smoking intensity, hypothetical tobacco price increases, and smoking habit change intention among current smokers in Shanghai
  Ruiping Wang, Yonggen Jiang, Xin Li, Qi Zhao, Meiying Zhu, Ying Guan, Genming Zhao
  Journal of International Medical Research.2019; 47(10): 5216.     CrossRef
• The impact of smoking cessation attempts on stress levels
  Seong-Jun Kim, Wonjeong Chae, Woo-Hyun Park, Min-Ho Park, Eun-Cheol Park, Sung-In Jang
  BMC Public Health.2019;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Seroreversion of hepatitis B surface antigen among subjects with resolved hepatitis B virus infection: A community‐based cohort study
  Ming‐Lun Yeh, Po‐Cheng Liang, Ching‐I Huang, Meng‐Hsuan Hsieh, Yi‐Hung Lin, Tyng‐Yuan Jang, Yu‐Ju Wei, Po‐Yao Hsu, Cheng‐Ting Hsu, Chih‐Wen Wang, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang,
  Journal of Gastroenterology and Hepatology.2021; 36(11): 3239.     CrossRef
• Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy
  A. R. Buonomo, G. Viceconte, R. Scotto, M. De Angelis, S. Tozza, F. Manganelli, A. G. Lanza, G. G. Di Costanzo, I. Gentile
  Infectious Diseases.2020; 52(3): 216.     CrossRef

Citations

Citations to this article as recorded by  

• A Systematic Review of Prognostic Factors in Patients with Cancer Receiving Palliative Radiotherapy: Evidence-Based Recommendations
  Alexander Tam, Emanuela Scarpi, Marco Cesare Maltoni, Romina Rossi, Alysa Fairchild, Kristopher Dennis, Marcus Vaska, Marc Kerba
  Cancers.2024; 16(9): 1654.     CrossRef
• Comparative assessment of the capability of machine learning-based radiomic models for predicting omental metastasis in locally advanced gastric cancer
  Ahao Wu, Lianghua Luo, Qingwen Zeng, Changlei Wu, Xufeng Shu, Pang Huang, Zhonghao Wang, Tengcheng Hu, Zongfeng Feng, Yi Tu, Yanyan Zhu, Yi Cao, Zhengrong Li
  Scientific Reports.2024;[Epub]     CrossRef
• Impact of Metastatic Pattern on Survival in Patients with Posterior Uveal Melanoma: A Retrospective Cohort Study
  Tine G. Hindso, Peter S. Jensen, Mette B. Sjøl, Kristoffer Nissen, Camilla W. Bjerrum, Eric von Benzon, Carsten Faber, Steen F. Urbak, Marco Donia, Inge M. Svane, Eva Ellebaek, Steffen Heegaard, Karine Madsen, Jens F. Kiilgaard
  Cancers.2024; 16(19): 3346.     CrossRef
• Orthotopic murine xenograft model of uveal melanoma with spontaneous liver metastasis
  Raquel Ramos, Eduard Cabré, Antònia Vinyals, Daniel Lorenzo, Josep R. Ferreres, Mar Varela, Montse Gomá, Maria José Paules, Cristina Gutierrez, Josep M. Piulats, Àngels Fabra, José M. Caminal
  Melanoma Research.2023; 33(1): 1.     CrossRef
• Determinants of Long-Term Survival in Metastatic Choroidal and Ciliary Body Melanoma
  Elina S. Rantala, Raffaele Parrozzani, Micaela M. Hernberg, Vanna Chiarion-Sileni, Tero T. Kivelä, Edoardo Midena
  American Journal of Ophthalmology.2023; 246: 258.     CrossRef
• Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma
  Di Wang, Bing Pan, Jin-Can Huang, Qing Chen, Song-Ping Cui, Ren Lang, Shao-Cheng Lyu
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Applications of Artificial Intelligence in Ocular Oncology
  Bhavna Chawla, Kusumitha B. Ganesh
  Advances in Ophthalmology and Optometry.2023; 8(1): 111.     CrossRef
• Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosis
  Luis P. del Carpio, María Asunción Algarra, Aida Sabaté‐Llobera, Alejo Rodriguez‐Vida, Susana Rossi‐Seoane, Sandra Ruiz, David Leiva, Emilio Ramos, Laura Lladò, Daniel Lorenzo, Cristina Gutierrez, Montserrat Cortes‐Romera, Josep M. Caminal, Josep M. Piula
  Cancer Medicine.2023; 12(13): 14062.     CrossRef
• Patients presenting with metastases: stage IV uveal melanoma, an international study
  Gaurav Garg, Paul T Finger, Tero T Kivelä, E Rand Simpson, Brenda L Gallie, Svetlana Saakyan, Anush G Amiryan, Vladimir Valskiy, Kimberly J Chin, Ekaterina Semenova, Stefan Seregard, Maria Filì, Matthew Wilson, Barrett Haik, Josep Maria Caminal, Jaume Cat
  British Journal of Ophthalmology.2022; 106(4): 510.     CrossRef
• Metastatic uveal melanoma: The final frontier
  Elina S. Rantala, Micaela M. Hernberg, Sophie Piperno-Neumann, Hans E. Grossniklaus, Tero T. Kivelä
  Progress in Retinal and Eye Research.2022; 90: 101041.     CrossRef
• The Application of Artificial Intelligence in the Analysis of Biomarkers for Diagnosis and Management of Uveitis and Uveal Melanoma: A Systematic Review
  Arshpreet Bassi, Saffire H Krance, Aidan Pucchio, Daiana R Pur, Rafael N Miranda, Tina Felfeli
  Clinical Ophthalmology.2022; Volume 16: 2895.     CrossRef
• A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol
  Anukriti Sharma, Ken B. Johnson, Bihua Bie, Emily E. Rhoades, Alper Sen, Yuri Kida, Jennifer Hockings, Alycia Gatta, Jacqueline Davenport, Connie Arcangelini, Jennifer Ritzu, Jennifer DeVecchio, Ron Hughen, Mei Wei, G. Thomas Budd, N. Lynn Henry, Charis E
  Technology in Cancer Research & Treatment.2022;[Epub]     CrossRef
• Nomogram, Decision Tree and Deep Learning Models to Predict Lymph Node Metastasis of Patients with Early Gastric Cancer: A Multi-Cohort Study
  Lulu Zhao, Weili Han, Penghui Niu, Yuanyuan Lu, Fan Zhang, Fuzhi Jiao, Xiadong Zhou, Wanqing Wang, Xiaoyi Luan, Mingyan He, Quanlin Guan, Yu-min Li, Yongzhan Nie, Kaichun Wu, Yingtai Chen
  SSRN Electronic Journal.2022;[Epub]     CrossRef
• ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma
  Lili Hao, Jiayang Yin, Hong Yang, Chaoxuan Li, Linxin Zhu, Lian Liu, Jingxiang Zhong
  Aging.2021; 13(3): 4045.     CrossRef
• Impact of staging on survival outcomes: a nationwide real-world cohort study of metastatic uveal melanoma
  Elina S. Rantala, Tero T. Kivelä, Micaela M. Hernberg
  Melanoma Research.2021; 31(3): 224.     CrossRef
• Classification trees for predicting obesity in school-aged children
  E.V. Anufrieva, V.N. Shershnev, O.P. Kovtun
  Profilakticheskaya meditsina.2021; 24(7): 30.     CrossRef
• Choroidal Melanoma with Ultrasound-Guided Episcleral Brachytherapy: Long-Term Results and Risk of Metastasis
  Beatriz Quiles, Jorge Mataix, José Luis Guinot, Isabel Wang, Victor De los Dolores, Marina Peña, Alonso La Rosa, Maribel Tortajada, Miguel Santos, Leoncio Arribas
  Ocular Oncology and Pathology.2021; 7(4): 280.     CrossRef
• Development of a Prognostic Nomogram for Liver Metastasis of Uveal Melanoma Patients Selected by Liver MRI
  Pascale Mariani, Sylvain Dureau, Alexia Savignoni, Livia Lumbroso-Le Rouic, Christine Levy-Gabriel, Sophie Piperno-Neumann, Manuel J. Rodrigues, Laurence Desjardins, Nathalie Cassoux, Vincent Servois
  Cancers.2019; 11(6): 863.     CrossRef
• Iterative treatment with surgery and radiofrequency ablation of uveal melanoma liver metastasis: Retrospective analysis of a series of very long-term survivors
  Vincent Servois, Toufik Bouhadiba, Sylvain Dureau, Carla Da Costa, Mohamed Maher Almubarak, Romain Foucher, Alexia Savignoni, Nathalie Cassoux, Gaelle Pierron, Pascale Mariani
  European Journal of Surgical Oncology.2019; 45(9): 1717.     CrossRef

Citations

Citations to this article as recorded by  

• Predicting Patterns of Distant Metastasis in Breast Cancer Patients following Local Regional Therapy Using Machine Learning
  Audrey Shiner, Alex Kiss, Khadijeh Saednia, Katarzyna J. Jerzak, Sonal Gandhi, Fang-I Lu, Urban Emmenegger, Lauren Fleshner, Andrew Lagree, Marie Angeli Alera, Mateusz Bielecki, Ethan Law, Brianna Law, Dylan Kam, Jonathan Klein, Christopher J. Pinard, Ale
  Genes.2023; 14(9): 1768.     CrossRef
• Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Breast Invasive Ductal Carcinoma Patients After Surgery: A Large Population-Based Study
  Yuqian Feng, Yiting Zhang, Yuying Xiang, Kaibo Guo, Huimin Jin, Shanming Ruan, Zhuoya Guan
  Frontiers in Surgery.2022;[Epub]     CrossRef
• Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer
  Jing Yang, Shu-Nan Qi, Hui Fang, Yong-Wen Song, Jing Jin, Yue-Ping Liu, Wei-Hu Wang, Yong Yang, Yu Tang, Hua Ren, Bo Chen, Ning-Ning Lu, Yuan Tang, Ning Li, Hao Jing, Shu-Lian Wang, Ye-Xiong Li
  The Breast.2021; 58: 72.     CrossRef
• Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer
  Koji Takada, Shinichiro Kashiwagi, Yuka Asano, Wataru Goto, Rika Kouhashi, Akimichi Yabumoto, Sae Ishihara, Tamami Morisaki, Masatsune Shibutani, Hiroaki Tanaka, Kosei Hirakawa, Masaichi Ohira
  BMC Women's Health.2021;[Epub]     CrossRef
• Nomogram for the personalisation of radiotherapy treatments in breast cancer patients
  Inmaculada Beato Tortajada, Carlos Ferrer Albiach, Virginia Morillo Macias
  The Breast.2021; 60: 255.     CrossRef
• Prognostic Factors and Nomograms to Predict Overall and Cancer-Specific Survival for Children with Wilms’ Tumor
  Fucai Tang, Hanbin Zhang, Zechao Lu, Jiamin Wang, Chengwu He, Zhaohui He
  Disease Markers.2019; 2019: 1.     CrossRef
• Score for the Survival Probability in Metastasis Breast Cancer: A Nomogram-Based Risk Assessment Model
  Zhenchong Xiong, Guangzheng Deng, Xinjian Huang, Xing Li, Xinhua Xie, Jin Wang, Zeyu Shuang, Xi Wang
  Cancer Research and Treatment.2018; 50(4): 1260.     CrossRef

Citations

Citations to this article as recorded by  

• Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment
  Hyo Seon Ryu, Hyun Jung Kim, Woong Bae Ji, Byung Chang Kim, Ji Hun Kim, Sung Kyung Moon, Sung Il Kang, Han Deok Kwak, Eun Sun Kim, Chang Hyun Kim, Tae Hyung Kim, Gyoung Tae Noh, Byung-Soo Park, Hyeung-Min Park, Jeong Mo Bae, Jung Hoon Bae, Ni Eun Seo, Cha
  Annals of Coloproctology.2024; 40(2): 89.     CrossRef
• Postoperative chemotherapy use and survival in non-high-risk young and high-risk old-aged patients with stage II colon cancer
  Tian Jin, Yingshuang Zhu, Wei Lu, Chenqin Le, Lijuan Wang, Qian Xiao, Kefeng Ding
  Holistic Integrative Oncology.2023;[Epub]     CrossRef
• Risk factors for recurrence in elderly patients with stage II colorectal cancer: a multicenter retrospective study
  Takuki Yagyu, Manabu Yamamoto, Akimitsu Tanio, Kazushi Hara, Ken Sugezawa, Chihiro Uejima, Kyoichi Kihara, Shigeru Tatebe, Yasuro Kurisu, Shunsuke Shibata, Toshio Yamamoto, Hiroshi Nishie, Setsujo Shiota, Hiroaki Saito, Takuji Naka, Kenji Sugamura, Kuniyu
  BMC Cancer.2022;[Epub]     CrossRef
• The role of high-risk features in stage II colon cancer after surgical treatment
  Patricio Bernardo Lynn, Garrett Yoon, Terry Li, Meng Cao, Michael Grieco, H. Leon Pachter, Russell C. Langan, Patrick Hilden, Joanna Sesti, Jason Maggi
  Surgery Open Digestive Advance.2022; 7: 100054.     CrossRef
• Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database
  Pietro Achilli, Jacopo Crippa, Fabian Grass, Kellie L. Mathis, Anne‐Lise D. D'Angelo, Mohamed A. Abd El Aziz, Courtney N. Day, William S. Harmsen, David W. Larson
  International Journal of Cancer.2021; 148(1): 161.     CrossRef
• Associations of P Score With Real-World Survival Improvement Offered by Adjuvant Chemotherapy in Stage II Colon Cancer: A Large Population-Based Longitudinal Cohort Study
  Qi Liu, Zezhi Shan, Dakui Luo, Sheng Zhang, Qingguo Li, Xinxiang Li
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Impact of Inadequate Number of Lymph Nodes Examined on Survival in Stage II Colon Cancer
  Qi Wu, Zhiyuan Zhang, Yijiao Chen, Jiang Chang, Yudong Jiang, Dexiang Zhu, Ye Wei
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients
  Yujin Lee, Inseok Park, Hyunjin Cho, Geumhee Gwak, Keunho Yang, Byung-Noe Bae
  Annals of Coloproctology.2021; 37(5): 298.     CrossRef
• Elderly High-Risk Stage II Colorectal Cancer Patients: Candidates for Improving Outcome?
  Min Ki Kim
  Annals of Coloproctology.2021; 37(5): 267.     CrossRef
• Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study
  Abdullah Sakin, Nurgul Yasar, Suleyman Sahin, Serdar Arici, Saban Secmeler, Orcun Can, Caglayan Geredeli, Cumhur Demir, Sener Cihan
  Journal of Oncology Pharmacy Practice.2020; 26(3): 619.     CrossRef
• Postoperative chemotherapy improves survival in patients with resected high‐risk Stage II colorectal cancer: results of a systematic review and meta‐analysis
  C. Simillis, H. K. S. I. Singh, T. Afxentiou, S. Mills, O. J. Warren, J. J. Smith, P. Riddle, M. Adamina, D. Cunningham, P. P. Tekkis
  Colorectal Disease.2020; 22(10): 1231.     CrossRef
• Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer
  Chao Zhang, Songcheng Yin, Yuen Tan, Jinyu Huang, Pengliang Wang, Wenbin Hou, Zhe Zhang, Huimian Xu
  American Journal of Clinical Oncology.2020; 43(4): 279.     CrossRef
• Mucinous Histology Might Be an Indicator for Enhanced Survival Benefit of Chemotherapy in Stage II Colon Cancer
  Yong Huang, Kuanxue Ge, Guangshun Fu, Junfeng Chu, Wei Wei
  Frontiers in Medicine.2020;[Epub]     CrossRef
• Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer
  Hongbo Li, Guangshun Fu, Wei Wei, Yong Huang, Zhenguang Wang, Tao Liang, Shuyun Tian, Honggang Chen, Wei Zhang
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Evaluating the Guiding Role of Elevated Pretreatment Serum Carcinoembryonic Antigen Levels for Adjuvant Chemotherapy in Stage IIA Colon Cancer: A Large Population-Based and Propensity Score-Matched Study
  Qi Liu, Yongqiang Huang, Dakui Luo, Sheng Zhang, Sanjun Cai, Qingguo Li, Yanlei Ma, Xinxiang Li
  Frontiers in Oncology.2019;[Epub]     CrossRef
• Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
  Kil-yong Lee, Ji Won Park, Ki-young Lee, Sangsik Cho, Yoon-Hye Kwon, Min Jung Kim, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park
  Scientific Reports.2019;[Epub]     CrossRef
• The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis
  Susan L. Green, David E. Dawe, Zoann Nugent, Winson Y. Cheung, Piotr M. Czaykowski
  Journal of Geriatric Oncology.2018;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer
  Gee-Chen Chang, Jin-Yuan Shih, Chong-Jen Yu, Heng-Sheng Chao, Cheng-Ta Yang, Chien-Chung Lin, Jen-Yu Hung, Sheng-Yen Hsiao, Chin-Chou Wang, Chih-Feng Chian, Te-Chun Hsia, Yuh-Min Chen, Chien-Feng Li
  PLOS ONE.2024; 19(5): e0303046.     CrossRef
• Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
  Jeng-Sen Tseng, Kuo-Hsuan Hsu, Zhe-Rong Zheng, Tsung-Ying Yang, Kun-Chieh Chen, Yen-Hsiang Huang, Kang-Yi Su, Sung-Liang Yu, Gee-Chen Chang
  Oncology.2021; 99(1): 32.     CrossRef
• Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI
  Chi-Lu Chiang, Hsu-Ching Huang, Chia-I Shen, Yung-Hung Luo, Yuh-Min Chen, Chao-Hua Chiu
  Targeted Oncology.2020; 15(4): 503.     CrossRef
• Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib
  Chih-Hsi Scott Kuo, Chi-Hsien Huang, Chien-Ying Liu, Stelios Pavlidis, Ho-Wen Ko, Fu-Tsai Chung, Tin-Yu Lin, Chih-Liang Wang, Yi-Ke Guo, Cheng-Ta Yang
  Targeted Oncology.2019; 14(4): 433.     CrossRef

Citations

Citations to this article as recorded by  

• Laparoscopic Radical Total Gastrectomy and Pancreatosplenectomy for Synchronous Cancer of the Stomach and Pancreas
  Motoki Ebihara, Kentoku Fujisawa, Shusuke Haruta, Hironori Uruga, Masaki Ueno
  Cureus.2024;[Epub]     CrossRef
• Synchronous primary multiple cancer: distal cholangiocarcinoma of the intrapancreatic common bile duct and intraductal papillary mucinous tumor associated with ductal adenocarcinoma of the pancreatic tail
  G.R. Setdikova, E.A. Stepanova, A.N. Verbovsky, A.V. Semenkov
  Pirogov Russian Journal of Surgery.2024; (8): 57.     CrossRef
• Pancreatoduodenectomy after Ivor-Lewis Santi oesophagectomy with gastric tube reconstruction. An European multicentre experience
  Alessandro D. Mazzotta, Pietro Addeo, Benedetto Ielpo, Michael Ginesini, Nicolas Regenet, Ugo Boggi, Philippe Bachellier, Olivier Soubrane
  Surgical Oncology.2024; 57: 102144.     CrossRef
• The importance of hsa-miR-28 in human malignancies
  Seyede Fatemeh Hosseini, Setareh Javanshir-giv, Hanieh Soleimani, Homa Mollaei, Farzad Sadri, Zohreh Rezaei
  Biomedicine & Pharmacotherapy.2023; 161: 114453.     CrossRef
• Synchronous double primary malignancies of the pancreatic body and extrahepatic bile duct treated with pancreatoduodenectomy and splenic artery resection following neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel: a case report
  Takahiro Murokawa, Takehiro Okabayashi, Kenta Sui, Motoyasu Tabuchi, Jun Iwata
  Surgical Case Reports.2022;[Epub]     CrossRef
• A Descriptive Study of the Types and Survival Patterns of Saudi Patients with Multiple Primary Solid Malignancies: A 30-Year Tertiary Care Center Experience
  Moustafa S. Alhamadh, Rakan B. Alanazi, Sultan T. Algarni, Ahmed Abdullah R. Alhuntushi, Mohammed Qasim Alshehri, Yusra Sajid Chachar, Mohammad Alkaiyat, Fouad Sabatin
  Current Oncology.2022; 29(7): 4941.     CrossRef
• Synchronous Pancreatic Ductal Adenocarcinoma in the Head and Tail, a Double Trouble: A Case Report and Literature Review
  Daniel Paramythiotis, Georgia Fotiadou, Eleni Karlafti, Ioanna Abba Deka, Georgios Petrakis, Elisavet Psoma, Xanthippi Mavropoulou, Filippos Kyriakidis, Smaro Netta, Stylianos Apostolidis
  Diagnostics.2022; 12(11): 2709.     CrossRef
• Ergebnisse nach Pankreaseingriffen aus Sicht der Betroffenen: Versorgungsforschung der Selbsthilfegruppe „Arbeitskreis der Pankreatektomierten e. V.“
  Ioannis Dimopoulos, Gabriele Meyer, Saleem Ibrahim Elhabash, Michele Sorleto, Carsten Gartung, Nils Ewald, Ulrich Klaus Fetzner, Lutz Otto, Friedhelm Möhlenbrock, Waldemar Uhl, Berthold Gerdes
  Zeitschrift für Gastroenterologie.2021; 59(03): 214.     CrossRef
• An extremely atypical presentation of esophageal squamous cell carcinoma with pancreatic and hepatic metastases
  Lei Zhang, Xin Long, Zheng-Nan Hu, Yu Wu, Jia Song, Bi-Xiang Zhang, Wei-Xun Chen
  Medicine.2021; 100(20): e25785.     CrossRef
• Clinical features of patients with pancreatic ductal adenocarcinoma with a history of other primary malignancies: A retrospective analysis
  Hironori Hayashi, Koji Amaya, Tomokazu Tokoro, Kosuke Mori, Shunsuke Takenaka, Yuya Sugimoto, Yuto Kitano, Toru Kurata, Shunsuke Kawai, Atsushi Hirose, Tomoya Tsukada, Masahide Kaji, Koichi Shimizu, Kiichi Maeda
  Molecular and Clinical Oncology.2021;[Epub]     CrossRef
• A Rare Case of Synchronous Esophageal and Pancreatic Malignancy
  Ali Khalifa, Arkady Broder
  Cureus.2021;[Epub]     CrossRef
• Synchronous concomitant pancreatic acinar cell carcin and gastric adenocarcinoma: A case report and review of literature
  Tian Fang, Ting-Ting Liang, Yi-Zhuo Wang, Hai-Tao Wu, Shu-Han Liu, Chang Wang
  World Journal of Clinical Cases.2021; 9(28): 8509.     CrossRef
• A novel long non‑coding RNA TTN‑AS1/microRNA‑589‑5p/FOXP1 positive feedback loop increases the proliferation, migration and invasion of pancreatic cancer cell lines
  Jing Zhao, Fang Wu, Jun Yang
  Oncology Letters.2021;[Epub]     CrossRef
• Multiple primary gastrointestinal tumors of gastric, pancreatic and rectal origin; a case report
  Abdullah Mohammed Aloraini, Hadeel Ayman Helmi, Nadia Abdulaziz Aljomah, Ahmad Mohmmed Zubaidi
  International Journal of Surgery Case Reports.2021; 89: 106610.     CrossRef
• A Newly Developed Pancreatic Adenocarcinoma in a Patient with Advanced Thyroid Cancer under Long-Term Sorafenib Use
  Min Ji Kim, Han-Sang Baek, Sung Hak Lee, Dong-Jun Lim
  International Journal of Thyroidology.2021; 14(2): 175.     CrossRef
• Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression
  Qing Han, Junhe Li, Jianping Xiong, Zhiwang Song
  Journal of Experimental & Clinical Cancer Research.2020;[Epub]     CrossRef
• Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy
  Oronzo Brunetti, Giuseppe Badalamenti, Simona De Summa, Angela Calabrese, Antonella Argentiero, Livia Fucci, Vito Longo, Domenico Galetta, Pia Maria Soccorsa Perrotti, Rosamaria Pinto, Daniela Petriella, Katia Danza, Stefania Tommasi, Francesco Leonetti,
  Cancers.2019; 11(6): 749.     CrossRef

Citations

Citations to this article as recorded by  

• The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the Literature
  Annika Belzer, Jolanta J. Pach, Kailyn Valido, Jonathan S. Leventhal
  American Journal of Clinical Dermatology.2024; 25(3): 435.     CrossRef
• Quality of Life Impact in Patients with Cutaneous Toxicities Caused by Epidermal Growth Factor Receptor Inhibitors and Immunotherapy
  Maria Mannino, Pietro Sollena, Alessandro Di Stefani, Ernesto Rossi, Ettore D’Argento, Giovanni Schinzari, Giampaolo Tortora, Ketty Peris
  Dermatology.2024; 240(4): 523.     CrossRef
• A comprehensive study of adverse effects of chemotherapy on female breast cancer patients in NORI Cancer Hospital, Islamabad in a developing country
  Areesha Abid, Humza Saeed, Uswa Iftikhar, Muhammad Khubaib Arshad, Muhammad Uzair Shahid, Tayyab Rasool, Faizan Fazal, Aman Goyal, Anum Akbar
  Journal of Oncology Pharmacy Practice.2024;[Epub]     CrossRef
• Chemotherapy induced alopecia in breast cancer patients: A monocentric prospective study
  Wala Ben Kridis, Olfa Boudawara, Afef Khanfir
  Breast Disease.2024; 43(1): 251.     CrossRef
• Impact of Xerosis in Patients With Cancer Receiving Epidermal Growth Factor Receptor or Mitogen-Activated Protein Kinase Inhibitors: ATIXI, A Non-Interventional, Prospective, Pilot Study
  Pietro Quaglino, Giuseppe Argenziano, Emi Dika, Michela Starace, Simone Amabile, Paolo Fava, Elvira Moscarella, Bianca Maria Piraccini, Alain Delarue, Olivia Dialla, Fabienne Zumaglini, Giampiero Girolomoni
  Dermatology Practical & Conceptual.2024; 14(4): e2024259.     CrossRef
• Global trends in adolescent and young adult female cancer burden, 1990-2021: insights from the Global Burden of Disease study
  Z. Huang, J. Wang, H. Liu, B. Wang, M. Qi, Z. Lyu, H. Liu
  ESMO Open.2024; 9(11): 103958.     CrossRef
• Dermatologic toxicities of chemotherapy: an educational intervention for skin of color women with breast cancer
  Maham Ahmad, Sabrina Saeed, Brianna Olamiju, Andrea Silber, Jonathan Leventhal
  International Journal of Women’s Dermatology.2023; 9(1): e073.     CrossRef
• Aloe vera gel for prevention of chemotherapy-induced hyperpigmentation: Four case reports
  Chia-Chi Chiu, Yi-Wen Hsiao, Yu-Chuan Wen, Tsung-Yen Chang, Shih-Hsiang Chen, Tang-Her Jaing
  Medicine.2023; 102(25): e34037.     CrossRef
• Skin-related Quality of Life in Patients with Lung Cancer Taking Oral Targeted Agents: A Single-Center, Cross-Sectional Study
  Joo Mi Park, Jeong Hye Kim
  Asian Oncology Nursing.2023; 23(2): 84.     CrossRef
• Dermatological Side Effects of Cancer Treatment: Psychosocial Implications—A Systematic Review of the Literature
  Vera Almeida, Daniela Pires, Marta Silva, Maribel Teixeira, Ricardo João Teixeira, André Louro, Maria Alzira Pimenta Dinis, Maria Ferreira, Ana Teixeira
  Healthcare.2023; 11(19): 2621.     CrossRef
• The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
  Brigitte Dreno, Kiarash Khosrotehrani, Giselle De Barros Silva, Julie Ryan Wolf, Delphine Kerob, Mark Trombetta, Etienne Atenguena, Pascale Dielenseger, Meng Pan, Florian Scotte, Ivan Krakowski, Mario Lacouture
  Supportive Care in Cancer.2023;[Epub]     CrossRef
• Effectiveness and Tolerability of Natural Herbal Formulations in the Prevention of Radiation-Induced Skin Toxicity in Patients Undergoing Radiotherapy
  Georgios Koukourakis, Georgios Pissakas, Christos G. Ganos, Gregory Sivolapenko, Dimitrios Kardamakis
  The International Journal of Lower Extremity Wounds.2022; 21(1): 75.     CrossRef
• Effects of the epidermal growth factor receptor inhibitor, gefitinib, on lipid and hyaluronic acid synthesis in cultured HaCaT keratinocytes
  Jang‐Hee Oh, Woojune Hur, Na Li, Seong Jin Jo
  Experimental Dermatology.2022; 31(6): 918.     CrossRef
• An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study
  Véronique Vendrely, Ander Mayor-Ibarguren, Aline Stennevin, Ariadna Ortiz-Brugués
  Dermatology and Therapy.2022; 12(3): 683.     CrossRef
• Nail pigmentation induced by chemotherapy: an observational study of patients with early-stage breast cancer
  Kuikui Jiang, Simei Shi, Qiulian Lin, Peng Sun, Luan Zhang, Zhongyu Yuan, Ruoxi Hong, Yanxia Shi, Xia Liu, Jingmin Zhang, Jiajia Huang, Xiwen Bi, Wen Xia, Qianyi Lu, Qiufan Zheng, Shusen Wang, Fei Xu
  Holistic Integrative Oncology.2022;[Epub]     CrossRef
• Cutaneous adverse events in patients receiving anticancer therapy in a tertiary hospital setting: the old and the new
  Hae‐Jin Suh, Ángeles Flórez, Víctor Sacristán, Ángeles Rodríguez Martinez, Francisca Fernández, Lucía Vilanova‐Trillo, Manuel Constenla, Manuel Pereiro
  International Journal of Dermatology.2021; 60(2): 208.     CrossRef
• The Impact of Acne, Atopic Dermatitis, Skin Toxicities and Scars on Quality of Life and the Importance of a Holistic Treatment Approach
  Brigitte Dreno, Jean Michel Amici, Ann Laure Demessant-Flavigny, Charlotte Wright, Charles Taieb, Seemal R Desai, Andrew Alexis
  Clinical, Cosmetic and Investigational Dermatology.2021; Volume 14: 623.     CrossRef
• Evaluating health related quality of life in outpatients receiving anti-cancer treatment: results from an observational, cross-sectional study
  Hae-Jin Suh Oh, Ángeles Flórez Menéndez, Víctor Sacristán Santos, Ángeles Rodríguez Martínez, Francisca Fernández Ribeiro, Lucía Vilanova-Trillo, Manuel Constenla Figueiras, Manuel Pereiro Ferreiros
  Health and Quality of Life Outcomes.2021;[Epub]     CrossRef
• Dermatologic conditions in women receiving systemic cancer therapy
  Michelle N. Ferreira, Julie Y. Ramseier, Jonathan S. Leventhal
  International Journal of Women's Dermatology.2019; 5(5): 285.     CrossRef

Citations

Citations to this article as recorded by  

• To Drink or Not to Drink? Investigating Alcohol’s Impact on Prostate Cancer Risk
  Aris Kaltsas, Michael Chrisofos, Evangelos N. Symeonidis, Athanasios Zachariou, Marios Stavropoulos, Zisis Kratiras, Ilias Giannakodimos, Asterios Symeonidis, Fotios Dimitriadis, Nikolaos Sofikitis
  Cancers.2024; 16(20): 3453.     CrossRef
• Combinations of lifestyle behaviors and cancer risk among Korean adults
  Ngoc Minh Luu, Thi Tra Bui, Thi Phuong Thao Tran, Thi Huyen Trang Nguyen, Jin-Kyoung Oh
  Scientific Reports.2023;[Epub]     CrossRef
• Cigarette smoking and prostate cancer: A systematic review and meta-analysis of prospective cohort studies
  Sarah Al-Fayez, Ashraf El-Metwally
  Tobacco Induced Diseases.2023; 21(February): 1.     CrossRef
• Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
  Taewon Hwang, Hyungseok Oh, Jung Ah Lee, Eo Jin Kim
  BMC Urology.2023;[Epub]     CrossRef
• Association Between Red and Processed Meat Consumption and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis
  Saeedeh Nouri-Majd, Asma Salari-Moghaddam, Azadeh Aminianfar, Bagher Larijani, Ahmad Esmaillzadeh
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Alcohol and Prostate Cancer: Time to Draw Conclusions
  Amanda J. Macke, Armen Petrosyan
  Biomolecules.2022; 12(3): 375.     CrossRef
• Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis
  Yan Jin, Jae Hung Jung, Woong Kyu Han, Eu Chang Hwang, Yoonmi Nho, Narae Lee, Ji Eun Yun, Kwang Suk Lee, Sang Hyub Lee, Hakmin Lee, Su-Yeon Yu
  Investigative and Clinical Urology.2022; 63(3): 251.     CrossRef
• Association between Relative Preference for Vegetables and Meat and Cancer Incidence in Korean Adults: A Nationwide Population-based Retrospective Cohort Study
  Ga-Eun Yie, An Na Kim, Hyun Jeong Cho, Minji Kang, Sungji Moon, Inah Kim, Kwang-Pil Ko, Jung Eun Lee, Sue K. Park
  Korean Journal of Community Nutrition.2021; 26(3): 211.     CrossRef
• Prostate Cancer Risk Calculators for Healthy Populations: Systematic Review
  Antonio Bandala-Jacques, Kevin Daniel Castellanos Esquivel, Fernanda Pérez-Hurtado, Cristobal Hernández-Silva, Nancy Reynoso-Noverón
  JMIR Cancer.2021; 7(3): e30430.     CrossRef
• Personalized 5-Year Prostate Cancer Risk Prediction Model in Korea Based on Nationwide Representative Data
  Yohwan Yeo, Dong Wook Shin, Jungkwon Lee, Kyungdo Han, Sang Hyun Park, Keun Hye Jeon, Jungeun Shin, Aesun Shin, Jinsung Park
  Journal of Personalized Medicine.2021; 12(1): 2.     CrossRef
• Lifestyles, health habits, and prostate cancer
  Tomoyuki Kawada
  Journal of Cancer Research and Clinical Oncology.2020; 146(6): 1623.     CrossRef
• Combination possibility and deep learning model as clinical decision-aided approach for prostate cancer
  Okyaz Eminaga, Omran Al-Hamad, Martin Boegemann, Bernhard Breil, Axel Semjonow
  Health Informatics Journal.2020; 26(2): 945.     CrossRef
• Tailored Biofunctionalized Biosensor for the Label-Free Sensing of Prostate-Specific Antigen
  Sachin Mishra, Eun-Seong Kim, Parshant Kumar Sharma, Zhi-Ji Wang, Sung-Hyun Yang, Ajeet Kumar Kaushik, Cong Wang, Yang Li, Nam-Young Kim
  ACS Applied Bio Materials.2020; 3(11): 7821.     CrossRef
• A Study on Risk Factors of the Incidence of Prostate Cancer Using National Health Insurance Service: Effects of BMI on Age
  Hye Sim Kim, Tae Hwa Go, Dae Ryong Kang, Jae Hung Jung, Sung Won Kwon, Sae Chul Kim, Jae Mann Song, Hyun Chul Chung, Sang Baek Koh
  Journal of Health Informatics and Statistics.2019; 44(4): 410.     CrossRef

Citations

Citations to this article as recorded by  

• Mechanisms of radioresistance and the underlying signaling pathways in colorectal cancer cells
  Josiane W. Tessmann, Murilo R. Rocha, Jose A. Morgado‐Díaz
  Journal of Cellular Biochemistry.2023; 124(1): 31.     CrossRef
• Nuclear Factor Erythroid 2-Related Factor 2/Kelch-Like ECH-Associated Protein 1 as a Predictor of Prognosis and Radiotherapy Resistance in Patients With Locally Advanced Rectal Cancer: A Prospective Analysis
  Ji Min Park, Shin Kim, Sung Uk Bae, Sang Jun Byun, Incheol Seo, Hye Won Lee
  Journal of Korean Medical Science.2023;[Epub]     CrossRef
• Radiotherapy resistance: identifying universal biomarkers for various human cancers
  Irina Larionova, Militsa Rakina, Elena Ivanyuk, Yulia Trushchuk, Alena Chernyshova, Evgeny Denisov
  Journal of Cancer Research and Clinical Oncology.2022; 148(5): 1015.     CrossRef
• Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models
  Moying Li, Qiyun Xiao, Nachiyappan Venkatachalam, Ralf-Dieter Hofheinz, Marlon R. Veldwijk, Carsten Herskind, Matthias P. Ebert, Tianzuo Zhan
  Therapeutic Advances in Medical Oncology.2022;[Epub]     CrossRef
• 131I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B–PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer—Biological Characterization, Biokinetics and Dosimetry
  Pedro Cruz-Nova, Blanca Ocampo-García, Dayan Andrea Carrión-Estrada, Paola Briseño-Diaz, Guillermina Ferro-Flores, Nallely Jiménez-Mancilla, José Correa-Basurto, Martiniano Bello, Libia Vega-Loyo, María del Rocío Thompson-Bonilla, Rosaura Hernández-Rivas,
  Molecules.2022; 27(17): 5446.     CrossRef
• Regulation of pancreatic cancer therapy resistance by chemokines
  Shailendra K. Gautam, Soumi Basu, Abhijit Aithal, Nidhi V. Dwivedi, Mansi Gulati, Maneesh Jain
  Seminars in Cancer Biology.2022; 86: 69.     CrossRef
• Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer
  Yuhong Chen, Biao Yang, Mingyang Chen, Zhaojun Li, Zhengyin Liao
  Frontiers in Bioscience-Landmark.2022;[Epub]     CrossRef
• Cancer Stem Cell Biomarkers Predictive of Radiotherapy Response in Rectal Cancer: A Systematic Review
  Marzia Mare, Lorenzo Colarossi, Veronica Veschi, Alice Turdo, Dario Giuffrida, Lorenzo Memeo, Giorgio Stassi, Cristina Colarossi
  Genes.2021; 12(10): 1502.     CrossRef
• ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer
  Lin He, Hao Chang, Yuhong Qi, Bing Zhang, Qiuju Shao
  Technology in Cancer Research & Treatment.2021;[Epub]     CrossRef
• Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model
  Noraini Nordin, Swee Keong Yeap, Heshu Sulaiman Rahman, Nur Rizi Zamberi, Nurul Elyani Mohamad, Nadiah Abu, Mas Jaffri Masarudin, Rasedee Abdullah, Noorjahan Banu Alitheen
  Molecules.2020; 25(11): 2670.     CrossRef
• Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells
  Xiaofei Li, Ruifang Tian, Lan Liu, Lihui Wang, Dong He, Ke Cao, John K. Ma, Chenghui Huang
  Journal of International Medical Research.2020;[Epub]     CrossRef
• Exploring the radiosensitizing potential of AZD8931: a pilot study on the human LoVo colorectal cancer cell line
  Cinzia Antognelli, Isabella Palumbo, Simonetta Piattoni, Monica Calzuola, Beatrice Del Papa, Vincenzo N. Talesa, Cynthia Aristei
  International Journal of Radiation Biology.2020; 96(11): 1504.     CrossRef
• The expression of long noncoding RNA CRCAL‐3 in colorectal cancer and its impacts on cell proliferation and migration
  Hui Chang, Guan‐Nan Wang, Ya‐Lan Tao
  Journal of Cellular Biochemistry.2019; 120(9): 15369.     CrossRef
• Pleiotropic Immune Functions of Chemokine Receptor 6 in Health and Disease
  Ranmali Ranasinghe, Rajaraman Eri
  Medicines.2018; 5(3): 69.     CrossRef
• Autophagy-regulating microRNAs: potential targets for improving radiotherapy
  Hongbin Li, Xiaodong Jin, Bing Chen, Ping Li, Qiang Li
  Journal of Cancer Research and Clinical Oncology.2018; 144(9): 1623.     CrossRef

Citations

Citations to this article as recorded by  

• Treatment de‐escalation for HPV+ oropharyngeal cancer: A systematic review and meta‐analysis
  Fausto Petrelli, Andrea Luciani, Antonio Ghidini, Sara Cherri, Paolo Gamba, Marta Maddalo, Paolo Bossi, Alberto Zaniboni
  Head & Neck.2022; 44(5): 1255.     CrossRef
• Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis
  Lu CHANG, Dongxu WANG, Shaoning KAN, Ming HAO, Huimin LIU, Zhijing YANG, Qianyun XIA, Weiwei LIU
  Journal of Applied Oral Science.2022;[Epub]     CrossRef
• Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques
  Tae Hyung Kim, In-Ho Cha, Eun Chang Choi, Hye Ryun Kim, Hyung Jun Kim, Se-Heon Kim, Ki Chang Keum, Chang Geol Lee
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Superficial circumflex iliac artery perforator flap for tongue reconstruction after hemiglossectomy for cancer: A case report
  Hong Loi Nguyen, Truong Phu M. Ho, Xuan Phu Tran, Thanh Xuan Nguyen
  Oral and Maxillofacial Surgery Cases.2021; 7(2): 100219.     CrossRef
• Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy
  Ambika Parmar, Michaelina Macluskey, Niall Mc Goldrick, David I Conway, Anne-Marie Glenny, Janet E Clarkson, Helen V Worthington, Kelvin KW Chan
  Cochrane Database of Systematic Reviews.2021;[Epub]     CrossRef
• Larynx-preserving reconstruction after extended base of the tongue resection
  Hideki Kadota, Junichi Fukushima, Sei Yoshida, Kenichi Kamizono, Muneyuki Masuda, Satoshi Toh, Ryuji Yasumatsu, Torahiko Nakashima, Takashi Nakagawa
  Journal of Plastic, Reconstructive & Aesthetic Surgery.2020; 73(4): 740.     CrossRef

Citations

Citations to this article as recorded by  

• Emerging treatment approaches for triple-negative breast cancer
  Maurizio Capuozzo, Venere Celotto, Mariachiara Santorsola, Antonio Fabozzi, Loris Landi, Francesco Ferrara, Assunta Borzacchiello, Vincenza Granata, Francesco Sabbatino, Giovanni Savarese, Marco Cascella, Francesco Perri, Alessandro Ottaiano
  Medical Oncology.2023;[Epub]     CrossRef
• Breast cancer treatment-related cardiovascular disturbances: advocacy for a watchful attitude in this never-ending story
  Charlène Rivier, Benoite Mery, Elise Rowinski, Sandrine Sotton, Wafa Bouleftour, Laurent Bertoletti, Olivier Tredan, Nicolas Magne
  Expert Opinion on Drug Safety.2022; 21(4): 453.     CrossRef
• Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach
  Manon Reda, Pauline Macaire, Hélène Bellio, Lionel Uwer, Silvia Ilie, Véronique Lorgis, Audrey Hennequin, Sylvain Ladoire, Emilie Rederstorff, Pierre Fumoleau, Nicolas Isambert, Nathalie Bonnin, Benoit You, Gilles Freyer, Isabelle Desmoulins, Antonin Schm
  Cancer Chemotherapy and Pharmacology.2022; 89(2): 197.     CrossRef
• Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
  Renaud Sabatier, Johan Martin, Cécile Vicier, Mathilde Guérin, Audrey Monneur, Magali Provansal, Louis Tassy, Carole Tarpin, Jean-Marc Extra, Frédéric Viret, Anthony Goncalves
  Journal of Clinical Medicine.2021; 10(6): 1272.     CrossRef
• The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry
  X. G. L. V. Pouwels, S. M. E. Geurts, B. L. T. Ramaekers, F. Erdkamp, B. E. P. J. Vriens, K. N. A. Aaldering, A. J. van de Wouw, M. W. Dercksen, T. J. Smilde, N. A. J. B. Peters, J. M. van Riel, M. J. Pepels, J. Heijnen-Mommers, M. A. Joore, V. C. G. Tjan
  Acta Oncologica.2020; 59(1): 82.     CrossRef
• Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer
  Isabelle Chabot, Qi Zhao, Yun Su
  Current Medical Research and Opinion.2020; 36(12): 2025.     CrossRef
• Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program
  William Jacot, Pierre‐Etienne Heudel, Julien Fraisse, Sophie Gourgou, Séverine Guiu, Florence Dalenc, Barbara Pistilli, Mario Campone, Christelle Levy, Marc Debled, Marianne Leheurteur, Marie Chaix, Claudia Lefeuvre, Anthony Goncalves, Lionel Uwer, Jean‐M
  International Journal of Cancer.2019; 145(12): 3359.     CrossRef

Citations

Citations to this article as recorded by  

• Uveal Melanoma: Comprehensive Review of Its Pathophysiology, Diagnosis, Treatment, and Future Perspectives
  Merve Kulbay, Emily Marcotte, Raheem Remtulla, Tsz Hin Alexander Lau, Manuel Paez-Escamilla, Kevin Y. Wu, Miguel N. Burnier
  Biomedicines.2024; 12(8): 1758.     CrossRef
• Impact of Metastatic Pattern on Survival in Patients with Posterior Uveal Melanoma: A Retrospective Cohort Study
  Tine G. Hindso, Peter S. Jensen, Mette B. Sjøl, Kristoffer Nissen, Camilla W. Bjerrum, Eric von Benzon, Carsten Faber, Steen F. Urbak, Marco Donia, Inge M. Svane, Eva Ellebaek, Steffen Heegaard, Karine Madsen, Jens F. Kiilgaard
  Cancers.2024; 16(19): 3346.     CrossRef
• Identification of a prognostic six-immune-gene signature and a nomogram model for uveal melanoma
  Binghua Yang, Yuxia Fan, Renlong Liang, Yi Wu, Aiping Gu
  BMC Ophthalmology.2023;[Epub]     CrossRef
• Prognostic Value of the Radiomics-Based Model in the Disease-Free Survival of Pretreatment Uveal Melanoma: An Initial Result
  Yaping Su, Xiaolin Xu, Fang Wang, Panli Zuo, Qinghua Chen, Wenbin Wei, Junfang Xian
  Journal of Computer Assisted Tomography.2023; 47(1): 151.     CrossRef
• Uveal melanoma pathobiology: Metastasis to the liver
  Prisca Bustamante, Léo Piquet, Solange Landreville, Julia V. Burnier
  Seminars in Cancer Biology.2021; 71: 65.     CrossRef
• Malignant uveal melanoma with metastatic recurrence to the pancreas: A case report
  Wei‐Chun Weng, Tzung‐Jiun Tsai, Wen‐Chi Chen, Jin‐Shiung Cheng, Wei‐Chih Sun
  Advances in Digestive Medicine.2021; 8(3): 178.     CrossRef
• Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort
  Paula Silva‐Rodríguez, Manuel Bande, Daniel Fernández‐Díaz, Nerea Lago‐Baameiro, María Pardo, María José Blanco‐Teijeiro, Fernando Domínguez, Lourdes Loidi, Antonio Piñeiro
  Acta Ophthalmologica.2021;[Epub]     CrossRef
• Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohort
  Laura Ling Ying Tan, Jiancheng Hong, Wei Lin Goh, Esther Wei Yin Chang, Valerie Shiwen Yang, Eileen Poon, Nagavalli Somasundaram, Mohamad Farid, Anita Sook Yee Chan, Jason Yongsheng Chan
  Scientific Reports.2020;[Epub]     CrossRef
• ЕФЕКТИВНІСТЬ РАДІОХВИЛЬОВОЇ (3,8 МГЦ) БЛОКЕКСЦИЗІЇ МЕЛАНОМИ ЦИЛІОХОРІОЇДАЛЬНОЇ ЛОКАЛІЗАЦІЇ
  O. V. Khomyakova
  Здобутки клінічної і експериментальної медицини.2020; (3): 173.     CrossRef

Citations

Citations to this article as recorded by  

• Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR
  Manish Chaudhary, Shubham Kumar, Paranjeet Kaur, Sanjeev Kumar Sahu, Amit Mittal
  Mini-Reviews in Medicinal Chemistry.2024; 24(7): 721.     CrossRef
• Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value
  Alessio Ardizzone, Valentina Bova, Giovanna Casili, Alberto Repici, Marika Lanza, Raffaella Giuffrida, Cristina Colarossi, Marzia Mare, Salvatore Cuzzocrea, Emanuela Esposito, Irene Paterniti
  Cells.2023; 12(7): 1002.     CrossRef
• Case Report of a Glioma Patient with Homozygous Missense Amino Acid Substitution in KDR Gene
  Kalyan Ram Uppaluri, Himavanth Reddy Kambalachenu, Hima Jyothi Challa, Saadvik Raghuram Y., Deepak Sharma, Ramya Gadicherla, Srinivas Ketavath, Kalyani Palasamudram, Sri Manjari K.
  Indian Journal of Medical and Paediatric Oncology.2023; 44(03): 356.     CrossRef
• FGFR families: biological functions and therapeutic interventions in tumors
  Qing Liu, Jiyu Huang, Weiwei Yan, Zhen Liu, Shu Liu, Weiyi Fang
  MedComm.2023;[Epub]     CrossRef
• Targeting transforming growth factor‐ß signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin
  Devesh Tewari, Anu Priya, Anusha Bishayee, Anupam Bishayee
  Clinical and Translational Medicine.2022;[Epub]     CrossRef
• Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines
  Katharina Klose, Eva‐Maria Packeiser, José‐Luis Granados‐Soler, Marion Hewicker‐Trautwein, Hugo Murua Escobar, Ingo Nolte
  Veterinary and Comparative Oncology.2022; 20(3): 641.     CrossRef
• Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy
  Elizabeth Liow, Nicholas Howard, Chol-Hee Jung, Bernard Pope, Bethany K. Campbell, Anne Nguyen, Michael Kerger, Jonathan B. Ruddle, Angelyn Anton, Benjamin Thomas, Kevin Chu, Philip Dundee, Justin S. Peters, Anthony J. Costello, Andrew S. Ryan, Christophe
  Clinical Genitourinary Cancer.2022; 20(5): 452.     CrossRef
• There are gremlins in prostate cancer
  Laura A. Sena, W. Nathaniel Brennen, John T. Isaacs
  Nature Cancer.2022; 3(5): 530.     CrossRef
• Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
  Yundong He, Weidong Xu, Yu-Tian Xiao, Haojie Huang, Di Gu, Shancheng Ren
  Signal Transduction and Targeted Therapy.2022;[Epub]     CrossRef
• Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
  Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Harshali Paliwal, Suresh Thareja, Prateek Pathak, Maria Grishina, Mariusz Jaremko, Abdul-Hamid Emwas, Jagat Pal Yadav, Amita Verma, Habibullah Khalilullah, Pradeep Kumar
  Pharmaceuticals.2022; 15(9): 1071.     CrossRef
• The FGF/FGFR system in the physiopathology of the prostate gland
  Arianna Giacomini, Elisabetta Grillo, Sara Rezzola, Domenico Ribatti, Marco Rusnati, Roberto Ronca, Marco Presta
  Physiological Reviews.2021; 101(2): 569.     CrossRef
• Signaling Pathways That Control Apoptosis in Prostate Cancer
  Amaal Ali, George Kulik
  Cancers.2021; 13(5): 937.     CrossRef
• A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer
  Fionnuala Crowley, Michelle Sterpi, Conor Buckley, Lauren Margetich, Shivani Handa, Zach Dovey
  Research and Reports in Urology.2021; Volume 13: 457.     CrossRef
• Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study
  F.J. Sherida H. Woei-A-Jin, Nir I. Weijl, Mark C. Burgmans, Arantza Fariña Sarasqueta, J. Tom van Wezel, Martin N.J.M. Wasser, Minneke J. Coenraad, Jacobus Burggraaf, Susanne Osanto
  The Oncologist.2021; 26(10): 854.     CrossRef
• Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment
  Peiyuan Zhang, Xiaohui Liu, Daniel Abegg, Toru Tanaka, Yuquan Tong, Raphael I. Benhamou, Jared Baisden, Gogce Crynen, Samantha M. Meyer, Michael D. Cameron, Arnab K. Chatterjee, Alexander Adibekian, Jessica L. Childs-Disney, Matthew D. Disney
  Journal of the American Chemical Society.2021; 143(33): 13044.     CrossRef
• Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer
  Clara H. Lee, Ann M. Decker, Frank C. Cackowski, Russell S. Taichman
  Cell Biology and Toxicology.2020; 36(2): 115.     CrossRef
• Brivanib, a multitargeted small‐molecule tyrosine kinase inhibitor, suppresses laser‐induced CNV in a mouse model of neovascular AMD
  Lele Li, Manhui Zhu, Wenli Wu, Bai Qin, Jiayi Gu, Yuanyuan Tu, Jianing Chen, Dong Liu, Yunwei Shi, Xiaojuan Liu, Aimin Sang, Dongmei Ding
  Journal of Cellular Physiology.2020; 235(2): 1259.     CrossRef
• In Vitro Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma Cells
  Arabinda Das, Jaime L. Martinez Santos, Mohammed Alshareef, Guilherme Bastos Ferreira Porto, Libby Kosnik Infinger, William A. Vandergrift, Scott M. Lindhorst, Abhay K. Varma, Sunil J. Patel, David Cachia
  Cancer Investigation.2020; 38(6): 349.     CrossRef
• Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma
  Ling Zhang, Xia Niu, Yanghui Bi, Heyang Cui, Hongyi Li, Xiaolong Cheng
  Technology in Cancer Research & Treatment.2020;[Epub]     CrossRef

• Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castrate-Resistant Prostate Cancer

  
  Adam M. Kase, John A. Copland, Winston Tan
  OncoTargets and Therapy.2020; Volume 13: 10499.     CrossRef
• Therapeutic implications of fibroblast growth factor receptor inhibitors in a combination regimen for solid tumors (Review)
  Hong Luo, Tao Zhang, Peng Cheng, Dong Li, Oleksandr Ogorodniitchouk, Chaimaa Lahmamssi, Ge Wang, Meiling Lan
  Oncology Letters.2020; 20(3): 2525.     CrossRef
• Dovitinib Triggers Apoptosis and Autophagic Cell Death by Targeting SHP-1/p-STAT3 Signaling in Human Breast Cancers
  Yi-Han Chiu, Yi-Yen Lee, Kuo-Chin Huang, Cheng-Chi Liu, Chen-Si Lin
  Journal of Oncology.2019; 2019: 1.     CrossRef
• Tumour-stroma ratio and 5-year mortality in gastric adenocarcinoma: a systematic review and meta-analysis
  Niko Kemi, Maarit Eskuri, Joonas H. Kauppila
  Scientific Reports.2019;[Epub]     CrossRef
• Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors
  Dan Wang, Li Yang, Weina Yu, Yi Zhang
  Expert Opinion on Investigational Drugs.2019; 28(10): 903.     CrossRef
• A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance
  Jacqueline Olender, Bi-Dar Wang, Travers Ching, Lana X. Garmire, Kaitlin Garofano, Youngmi Ji, Tessa Knox, Patricia Latham, Kenneth Nguyen, Johng Rhim, Norman H. Lee
  Molecular Cancer Research.2019; 17(10): 2115.     CrossRef
• Recent Advances in Prostate Cancer Treatment and Drug Discovery
  Ekaterina Nevedomskaya, Simon J. Baumgart, Bernard Haendler
  International Journal of Molecular Sciences.2018; 19(5): 1359.     CrossRef

Citations

Citations to this article as recorded by  

• Multiparametric Quantitative Imaging in Risk Prediction: Recommendations for Data Acquisition, Technical Performance Assessment, and Model Development and Validation
  Erich P. Huang, Gene Pennello, Nandita M. deSouza, Xiaofeng Wang, Andrew J. Buckler, Paul E. Kinahan, Huiman X. Barnhart, Jana G. Delfino, Timothy J. Hall, David L. Raunig, Alexander R. Guimaraes, Nancy A. Obuchowski
  Academic Radiology.2023; 30(2): 196.     CrossRef
• Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast
  Yixin Cheng, Pengkun Zhang, Yulin Huang, Zhihui Zhang, Ru Tang, Feng Chi, Jia-Yuan Sun, Zhenyu He
  BMJ Open.2023; 13(2): e065312.     CrossRef
• Developing and validating nomograms for predicting the survival in patients with clinical local-advanced gastric cancer
  Chong Hou, Fangxu Yin, Yipin Liu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Development and validation of a risk stratification nomogram for predicting prognosis in bone metastatic breast cancer
  Niuniu Hou, Jun Yi, Zhe Wang, Lu Yang, Ying Wu, Meiling Huang, Guangdong Hou, Rui Ling
  Medicine.2021; 100(6): e24751.     CrossRef
• A Nomogram for Predicting Survival in Patients With Breast Cancer Liver Metastasis: A Population-Based Study
  Yu Xiong, Xia Shi, Qi Hu, Xingwei Wu, Enwu Long, Yuan Bian
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Prognostic Factors and a Nomogram Predicting Survival in Patients with Breast Ductal Carcinoma in situ with Microinvasion: A Population-Based Study
  Yi-Zi Zheng, Hong-Bin Qin, Zi-Zheng Li, He-Sheng Jiang, Greg Zhang, Shi-Wei Yang, Xian-Ming Wang, Yang-Chun Xu, Zhen-Han Deng, Guo-Wen Liu
  Clinical Epidemiology.2021; Volume 13: 1095.     CrossRef
• The E3 Ubiquitin Ligase Cbl-b Predicts Favorable Prognosis in Breast Cancer
  Xiuming Liu, Yuee Teng, Xin Wu, Zhi Li, Bowen Bao, Yunpeng Liu, Xiujuan Qu, Lingyun Zhang
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Prognostic Factors for Premenopausal Women with Distant Metastatic Breast Cancer
  Jeungho Seung, Jai Min Ryu, Seok Jin Nam, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Byung Joo Chae, Seok Won Kim
  Journal of Breast Disease.2020; 8(1): 1.     CrossRef
• Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer Patients
  Yujie Lu, Yiwei Tong, Jiahui Huang, Lin Lin, Jiayi Wu, Xiaochun Fei, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Independent risk factors evaluation for overall survival and cancer-specific survival in thyroid cancer patients with bone metastasis
  Yuexin Tong, Zhangheng Huang, Chuan Hu, Changxing Chi, Meng Lv, Pengfei Li, Chengliang Zhao, Youxin Song
  Medicine.2020; 99(36): e21802.     CrossRef
• A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study
  Wen Zhao, Lei Wu, Andi Zhao, Mi Zhang, Qi Tian, Yanwei Shen, Fan Wang, Biyuan Wang, Le Wang, Ling Chen, Xiaoai Zhao, Danfeng Dong, Lingxiao Zhang, Jin Yang
  BMC Cancer.2020;[Epub]     CrossRef
• Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery
  Hong Lin, Yanxuan Wu, Guoxi Liang, Liming Chen, Anna Sapino
  PLOS ONE.2020; 15(11): e0242155.     CrossRef
• Predictors of time to death after distant recurrence in breast cancer patients
  Victoria Sopik, Ping Sun, Steven A. Narod
  Breast Cancer Research and Treatment.2019; 173(2): 465.     CrossRef
• Prognostic nomogram for patients with non-metastatic HER2 positive breast cancer in a prospective cohort
  Chuanxu Luo, Xiaorong Zhong, Zhu Wang, Yu Wang, Yanping Wang, Ping He, Qian Peng, Hong Zheng
  The International Journal of Biological Markers.2019; 34(1): 41.     CrossRef
• B2 Prognostic Score: External Validation of a Clinical Decision-making Tool for Metastatic Breast Cancer
  Tanja Nadine Stueber, Manfred Wischnewsky, Elena Leinert, Joachim Diessner, Catharina Bartmann, Roland Gregor Stein, Achim Woeckel
  Clinical Breast Cancer.2019; 19(5): 333.     CrossRef
• Development and Validation of a Nomogram for Predicting Survival in Male Patients With Breast Cancer
  Siying Chen, Yang Liu, Jin Yang, Qingqing Liu, Haisheng You, Yalin Dong, Jun Lyu
  Frontiers in Oncology.2019;[Epub]     CrossRef
• Could local surgery improve survival in de novo stage IV breast cancer?
  Zhenchong Xiong, Guangzheng Deng, Jin Wang, Xing Li, Xinhua Xie, Zeyu Shuang, Xi Wang
  BMC Cancer.2018;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Improving colorectal cancer in Alberta, Canada: a qualitative study of patients and close contacts’ perceptions on diagnosis following an emergency department presentation
  Anna Pujadas Botey, Ashley J. Watson, Paula J. Robson
  BMC Health Services Research.2024;[Epub]     CrossRef
• Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer
  Malin Ljunggren, Caroline E. Weibull, Gabriella Palmer, Emerik Osterlund, Bengt Glimelius, Anna Martling, Caroline Nordenvall
  International Journal of Cancer.2023; 152(3): 363.     CrossRef
• Cancer awareness in older adults: Results from the Spanish Onco-barometer cross-sectional survey
  Dafina Petrova, Marina Pollán, Rocio Garcia-Retamero, Miguel Rodríguez-Barranco, Andrés Catena, Lucia Castillo Portellano, Maria-José Sánchez
  International Journal of Nursing Studies.2023; 140: 104466.     CrossRef
• Perceived barriers to early presentation and symptom-specific time to seek medical advice for possible colorectal cancer symptoms among Palestinians
  Mohamedraed Elshami, Mohammed Ayyad, Fatma Khader Hamdan, Mohammed Alser, Ibrahim Al-Slaibi, Shoruq Ahmed Naji, Balqees Mustafa Mohamad, Wejdan Sudki Isleem, Adela Shurrab, Bashar Yaghi, Yahya Ayyash Qabaja, Mohammad Fuad Dwikat, Raneen Raed Sweity, Remah
  Scientific Reports.2023;[Epub]     CrossRef
• Influence of Diagnostic Delay on Survival Rates for Patients with Colorectal Cancer
  María Padilla-Ruiz, María Morales-Suárez-Varela, Francisco Rivas-Ruiz, Julia Alcaide, Esperanza Varela-Moreno, Irene Zarcos-Pedrinaci, Teresa Téllez, Nerea Fernández-de Larrea-Baz, Marisa Baré, Amaia Bilbao, Cristina Sarasqueta, Urko Aguirre-Larracoechea,
  International Journal of Environmental Research and Public Health.2022; 19(6): 3626.     CrossRef
• Patient delay to diagnosis and its predictors among colorectal cancer patients: A cross-sectional study based on the Theory of Planned Behavior
  Ying Jin, Mei-Chun Zheng, Xia Yang, Ting-Lan Chen, Jun-E Zhang
  European Journal of Oncology Nursing.2022; 60: 102174.     CrossRef
• Advanced stage presentation and its determinant factors among colorectal cancer patients in Amhara regional state Referral Hospitals, Northwest Ethiopia
  Mulugeta Wassie, Debrework Tesgera Beshah, Yenework Mulu Tiruneh, Negar Rezaei
  PLOS ONE.2022; 17(10): e0273692.     CrossRef
• Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species–induced autophagy
  Nan Che, Zhaoting Yang, Xingzhe Liu, Mengxuan Li, Ying Feng, Chengye Zhang, Chao Li, Yan Cui, Yanhua Xuan
  Journal of Cellular and Molecular Medicine.2021; 25(4): 2110.     CrossRef
• Assessing Knowledge, Physician Interactions and Patient-Reported Barriers to Colorectal Cancer Screening Among Arab Americans in Dearborn, Michigan
  Fatima Saad, Mariam Ayyash, Marwa Ayyash, Nadine Elhage, Iman Ali, Mona Makki, Hiam Hamade, R. Alexander Blackwood
  Journal of Community Health.2020; 45(5): 900.     CrossRef
• Targeting Receptor Kinases in Colorectal Cancer
  Marilina García-Aranda, Maximino Redondo
  Cancers.2019; 11(4): 433.     CrossRef

Citations

Citations to this article as recorded by  

• Exploring age-standardized cancer incidence rates and regional disparities: A retrospective cohort study of 8 major cancers in South Korea
  Dagyeong Lee, Hye-won Yun, Nayeon Kim, Juwon Park, Kyu-won Jung, Mina Suh, Dong Wook Shin
  Cancer Epidemiology.2024; 91: 102594.     CrossRef
• Descriptive Analysis of Gastric Cancer Mortality in Korea, 2000-2020
  Tung Hoang, Hyeongtaek Woo, Sooyoung Cho, Jeeyoo Lee, Sayada Zartasha Kazmi, Aesun Shin
  Cancer Research and Treatment.2023; 55(2): 603.     CrossRef
• Changes in spatial clusters of cancer incidence and mortality over 15 years in South Korea: Implication to cancer control
  Cham Thi Nguyen, Insang Song, Inkyung Jung, Yoon‐Jung Choi, Sun‐Young Kim
  Cancer Medicine.2023; 12(16): 17418.     CrossRef
• Spatio-temporal trends of the age-at-menarche percentiles among Portuguese women since 1920
  Vitor Rodrigues, Rui Martins, Bruno de Sousa
  BMC Women's Health.2023;[Epub]     CrossRef
• Regional disparities in major cancer incidence in Korea, 1999-2018
  Eun Hye Park, Mee Joo Kang, Kyu-Won Jung, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Chang Kyun Choi, Jeong-Soo Im, Hong Gwan Seo
  Epidemiology and Health.2023; 45: e2023089.     CrossRef
• Estimation of Utility Weights for Prostate-related Health States in Korea
  Seon-Ha Kim, Minsu Ock, Min-Woo Jo, Sungchan Park
  Journal of Preventive Medicine and Public Health.2022; 55(3): 243.     CrossRef
• A comparison of quality of life between patients with small and large gastric remnant volumes after gastrectomy for gastric cancer
  Jae-Seok Min, Sang-Ho Jeong, Ji-Ho Park, Taehan Kim, Eun-Jung Jung, Young-Tae Ju, Chi-Young Jeong, Ju-Yeon Kim, Miyeong Park, Young-Joon Lee
  Medicine.2021; 100(33): e26954.     CrossRef
• Spatial epidemiologic analysis of the liver cancer and gallbladder cancer incidence and its determinants in South Korea
  Jieun Jang, Dae-Sung Yoo, Byung Chul Chun
  BMC Public Health.2021;[Epub]     CrossRef
• Spatial distribution and determinants of thyroid cancer incidence from 1999 to 2013 in Korea
  Jieun Jang, Dae-Sung Yoo, Byung Chul Chun
  Scientific Reports.2021;[Epub]     CrossRef
• Family History of Gastric Cancer and Helicobacter pylori Treatment
  Il Ju Choi, Chan Gyoo Kim, Jong Yeul Lee, Young-Il Kim, Myeong-Cherl Kook, Boram Park, Jungnam Joo
  New England Journal of Medicine.2020; 382(5): 427.     CrossRef
• Application of Epidemiological Geographic Information System: An Open-Source Spatial Analysis Tool Based on the OMOP Common Data Model
  Jaehyeong Cho, Seng Chan You, Seongwon Lee, DongSu Park, Bumhee Park, George Hripcsak, Rae Woong Park
  International Journal of Environmental Research and Public Health.2020; 17(21): 7824.     CrossRef

Citations

Citations to this article as recorded by  

• RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants
  Kazumi Nishino, Jin-Yuan Shih, Kazuhiko Nakagawa, Martin Reck, Edward B. Garon, Michelle Carlsen, Tomoko Matsui, Carla Visseren-Grul, Ernest Nadal
  JTO Clinical and Research Reports.2024; 5(2): 100624.     CrossRef
• Epidermal Growth Factor Receptor Exon 19 Deletion Subtypes Do Not Influence Survival Outcomes Following First-line Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Advanced Nonsmall Cell Lung Cancer Patients
  Yan-Jei Tang, John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, Chiao-En Wu
  Journal of Cancer Research and Practice.2024; 11(1): 28.     CrossRef
• CRISPR-Based Fluorescent Reporter (CBFR) Assay for Sensitive, Specific, Inexpensive, and Visual Detection of a Specific EGFR Exon 19 Deletion in NSCLC
  Pouya Salehipour, Mojdeh Mahdiannasser, Ghazal Sedaghat Shayegan, Kimia Shankaie, Mina Tabrizi, Majid Mojarrad, Mohammad Hossein Modarressi
  Molecular Biotechnology.2023; 65(5): 807.     CrossRef
• Endobronchial ultrasound‐guided re‐biopsy of non–small cell lung cancer with acquired resistance after EGFR tyrosine kinase inhibitor treatment
  Kyung Soo Hong, Jinmo Cho, Jong Geol Jang, Min Hye Jang, June Hong Ahn
  Thoracic Cancer.2023; 14(4): 363.     CrossRef
• Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors
  Chun-Ta Huang, Chih-An Lin, Te-Jen Su, Ching-Yao Yang, Tzu-Hsiu Tsai, Chia-Lin Hsu, Wei-Yu Liao, Kuan-Yu Chen, Chao-Chi Ho, Chong-Jen Yu
  BMC Cancer.2023;[Epub]     CrossRef
• Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations
  Jinfei Si, Yue Hao, Jingwen Wei, Jing Xiang, Chunwei Xu, Qiuping Shen, Zhengbo Song
  BMC Pulmonary Medicine.2023;[Epub]     CrossRef
• FRET probe for detecting two mutations in one EGFR mRNA
  Myat Thu, Kouta Yanai, Hajime Shigeto, Shohei Yamamura, Kazunori Watanabe, Takashi Ohtsuki
  The Analyst.2023; 148(11): 2626.     CrossRef
• Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
  Michael J. Grant, Jacqueline V. Aredo, Jacqueline H. Starrett, Paul Stockhammer, Iris K. van Alderwerelt van Rosenburgh, Anna Wurtz, Andrew J. Piper-Valillo, Zofia Piotrowska, Christina Falcon, Helena A. Yu, Charu Aggarwal, Dylan Scholes, Tejas Patil, Chr
  Clinical Cancer Research.2023; 29(11): 2123.     CrossRef
• NSCLC presents metabolic heterogeneity, and there is still some leeway for EGF stimuli in EGFR-mutated NSCLC
  Cindy Mendes, Isabel Lemos, Inês Francisco, Teresa Almodôvar, Fernando Cunha, Cristina Albuquerque, Luís G. Gonçalves, Jacinta Serpa
  Lung Cancer.2023; 182: 107283.     CrossRef
• Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first‐line tyrosine kinase inhibitors: A single‐center ambispective cohort study
  Yangchun Gu, Jinyu Yu, Haifeng Hu, Hua Zhang, Baoshan Cao, Li Liang
  Thoracic Cancer.2023; 14(31): 3147.     CrossRef
• Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
  Jia-Shiuan Ju, Allen Chung-Cheng Huang, Pi-Hung Tung, Chi-Hsien Huang, Tzu-Hsuan Chiu, Chin-Chou Wang, How-Wen Ko, Fu-Tsai Chung, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang
  Scientific Reports.2023;[Epub]     CrossRef
• Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation
  Chi‐Hsien Huang, Jia‐Shiuan Ju, Tzu‐Hsuan Chiu, Allen Chung‐Cheng Huang, Pi‐Hung Tung, Chin‐Chou Wang, Chien‐Ying Liu, Fu‐Tsai Chung, Yueh‐Fu Fang, Yi‐Ke Guo, Chih‐Hsi Scott Kuo, Cheng‐Ta Yang
  International Journal of Cancer.2022; 150(4): 626.     CrossRef
• The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
  Yen-Hsiang Huang, Kuo-Hsuan Hsu, Chun-Shih Chin, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J.W. Chen, Gee-Chen Chang
  Cancer Research and Treatment.2022; 54(2): 434.     CrossRef
• Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer
  Le-Tian Huang, Shu-Ling Zhang, Cheng-Bo Han, Jie-Tao Ma
  Lung Cancer.2022; 166: 9.     CrossRef
• Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI
  John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, Chiao-En Wu
  Cancers.2022; 14(4): 977.     CrossRef
• Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer
  Minehiko Inomata, Masahiro Matsumoto, Isami Mizushima, Kana Hayashi, Zenta Seto, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
  The Egyptian Journal of Bronchology.2022;[Epub]     CrossRef
• Pretreatment Neutrophil-to-Lymphocyte Ratio and Smoking History as Prognostic Factors in Advanced Non–Small Cell Lung Cancer Patients Treated with Osimertinib
  Ji Young Park, Seung Hun Jang, Chang Youl Lee, Taehee Kim, Soo Jie Chung, Ye Jin Lee, Hwan Il Kim, Joo-Hee Kim, Sunghoon Park, Yong Il Hwang, Ki-Suck Jung
  Tuberculosis and Respiratory Diseases.2022; 85(2): 155.     CrossRef
• Optimizing Patient Outcomes Through Sequential EGFR TKI Treatment in Asian Patients With EGFR Mutation-Positive NSCLC
  Rong Liu, Jianying Zhou, Xia Ling
  Clinical Medicine Insights: Oncology.2022;[Epub]     CrossRef
• State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan
  Yung-Hung Luo, Kung-Hao Liang, Hsu-Ching Huang, Chia-I Shen, Chi-Lu Chiang, Mong-Lien Wang, Shih-Hwa Chiou, Yuh-Min Chen
  International Journal of Molecular Sciences.2022; 23(13): 7037.     CrossRef
• Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT)
  Urška Janžič, Nina Turnšek, Mircea Dediu, Ivan Shterev Donev, Roxana Lupu, Gabriela Teodorescu, Tudor E. Ciuleanu, Adam Pluzanski
  Current Oncology.2022; 29(8): 5833.     CrossRef
• Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study
  Yangyang Shi, Hailing Xu, William Y. Raynor, Jiapei Ding, Ling Lin, Chao Zhou, Wei Wang, Yinnan Meng, Xiaomai Wu, Xiaofeng Chen, Dongqing Lv, Haihua Yang
  Life.2022; 12(12): 1954.     CrossRef
• Association of hOGG1‐Cys variants with occurrence of p53 and EGFR deletion mutations in non‐small cell lung cancer
  Ming‐Jenn Chen, Ching‐Ju Shen, Lee Wang, Po‐Ming Chen, Chih‐Yi Chen, Huei Lee
  Thoracic Cancer.2021; 12(4): 534.     CrossRef
• The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy
  Wen-Chien Cheng, Te-Chun Hsia, Chih-Yen Tu, Hung-Jen Chen
  OncoTargets and Therapy.2021; Volume 13: 13425.     CrossRef
• EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
  Jeng-Shiuan Tsai, Po-Lan Su, Szu-Chun Yang, Chao-Chun Chang, Chia-Ying Lin, Yi-Ting Yen, Yau-Lin Tseng, Wu-Wei Lai, Chien-Chung Lin, Wu-Chou Su
  Journal of the Formosan Medical Association.2021; 120(9): 1729.     CrossRef
• The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
  Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J. W. Chen, Tsung-Ying Yang, Gee-Chen Chang
  Scientific Reports.2021;[Epub]     CrossRef
• First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer
  Allen Chung-Cheng Huang, Chi-Hsien Huang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, Pi-Hung Tung, Chin-Chou Wang, Chien-Ying Liu, Fu-Tsai Chung, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang
  Therapeutic Advances in Medical Oncology.2021;[Epub]     CrossRef
• Association of EGFR Tyrosine Kinase Inhibitor Treatment With Progression-Free Survival Among Taiwanese Patients With Advanced Lung Adenocarcinoma and EGFR Mutation
  Po-Yen Chen, Chin-Chou Wang, Chien-Ning Hsu, Chung-Yu Chen
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer
  Xinying Li, Cen Chen, Zimu Wang, Jiaxin Liu, Wei Sun, Kaikai Shen, Yanling Lv, Suhua Zhu, Ping Zhan, Tangfeng Lv, Yong Song
  Cancer Cell International.2021;[Epub]     CrossRef
• Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience
  Paola Ulivi, Elisabetta Petracci, Matteo Canale, Ilaria Priano, Laura Capelli, Daniele Calistri, Elisa Chiadini, Paola Cravero, Alice Rossi, Angelo Delmonte, Lucio Crinò, Giuseppe Bronte
  Biomedicines.2021; 9(10): 1299.     CrossRef
• Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non–small cell lung cancer patients
  Po-Hsin Lee, Kun-Chieh Chen, Kuo-Hsuan Hsu, Yen-Hsiang Huang, Jeng-Sen Tseng, Tsung-Ying Yang, Gee-Chen Chang
  Anti-Cancer Drugs.2021; 32(10): 1099.     CrossRef
• Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy
  Alessandro Dal Maso, Martina Lorenzi, Elisa Roca, Sara Pilotto, Marianna Macerelli, Valentina Polo, Fabiana Letizia Cecere, Alessandro Del Conte, Giorgia Nardo, Vanessa Buoro, Daniela Scattolin, Sara Monteverdi, Loredana Urso, Elisabetta Zulato, Stefano F
  Clinical Lung Cancer.2020; 21(1): 1.     CrossRef
• Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
  Ching-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, Kuan-Yu Chen, Tzu-Hsiu Tsai, Chia-Lin Hsu, Kang-Yi Su, Yih-Leong Chang, Chen-Tu Wu, Chia-Chi Hsu, Bin-Chi Liao, Wei-Hsun Hsu, Jih-Hsiang Lee, Chia-Chi Lin, Jin-Yuan Shih, James C.-H. Yang, Chong-Jen Yu
  European Journal of Cancer.2020; 124: 110.     CrossRef
• Comparison detection methods for EGFR in formalin-fixed paraffin-embedded tissues of patients with NSCLC
  Xiaojie Fan, Xiaoxiao Wang, Meng Zhang, Huiyan Deng, Yueping Liu
  Pathology - Research and Practice.2020; 216(1): 152783.     CrossRef
• Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation
  Sang Hoon Lee, Eun Young Kim, Arum Kim, Yoon Soo Chang
  Cancer Biology & Therapy.2020; 21(8): 741.     CrossRef
• Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI
  Chi-Lu Chiang, Hsu-Ching Huang, Chia-I Shen, Yung-Hung Luo, Yuh-Min Chen, Chao-Hua Chiu
  Targeted Oncology.2020; 15(4): 503.     CrossRef
• An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
  Shang-Gin Wu, Chi-Lu Chiang, Chien-Ying Liu, Chin-Chou Wang, Po-Lan Su, Te-Chun Hsia, Jin-Yuan Shih, Gee-Chen Chang
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Refined Stratification Based on Baseline Concomitant Mutations and Longitudinal Circulating Tumor DNA Monitoring in Advanced EGFR-Mutant Lung Adenocarcinoma Under Gefitinib Treatment
  Jianchun Duan, JiaChen Xu, Zhijie Wang, Hua Bai, Ying Cheng, Tongtong An, Hongjun Gao, Kai Wang, Qing Zhou, Yanping Hu, Yong Song, Cuimin Ding, Feng Peng, Li Liang, Yi Hu, Cheng Huang, Caicun Zhou, Yuankai Shi, Jiefei Han, Di Wang, Yanhua Tian, Zhenlin Ya
  Journal of Thoracic Oncology.2020; 15(12): 1857.     CrossRef
• A Highly Sensitive Next-Generation Sequencing-Based Genotyping Platform for EGFR Mutations in Plasma from Non-Small Cell Lung Cancer Patients
  Jung-Young Shin, Jeong-Oh Kim, Mi-Ran Lee, Seo Ree Kim, Kyongmin Sarah Beck, Jin Hyoung Kang
  Cancers.2020; 12(12): 3579.     CrossRef
• Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy
  Minehiko Inomata, Kenji Azechi, Naoki Takata, Kana Hayashi, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
  Diagnostics.2020; 10(12): 1006.     CrossRef
• Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer
  Jiyun Lee, Joon Ho Shim, Woong-Yang Park, Hee Kyung Kim, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
  Cancer Research and Treatment.2019; 51(1): 408.     CrossRef
• Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations
  Yen‐Ting Lin, Jin‐Shing Chen, Wei‐Yu Liao, Chao‐Chi Ho, Chia‐Lin Hsu, Ching‐Yao Yang, Kuan‐Yu Chen, Jih‐Hsiang Lee, Zhong‐Zhe Lin, Jin‐Yuan Shih, James Chih‐Hsin Yang, Chong‐Jen Yu
  International Journal of Cancer.2019; 144(11): 2887.     CrossRef
• Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib
  Chih-Hsi Scott Kuo, Chi-Hsien Huang, Chien-Ying Liu, Stelios Pavlidis, Ho-Wen Ko, Fu-Tsai Chung, Tin-Yu Lin, Chih-Liang Wang, Yi-Ke Guo, Cheng-Ta Yang
  Targeted Oncology.2019; 14(4): 433.     CrossRef
• Frecuencia de mutación T790M determinada por biopsia líquida en pacientes con cáncer pulmonar de células no pequeñas después de la progresión a inhibidores de tirosina cinasa contra EGFR en primera línea
  Jorge Arturo Alatorre-Alexander, Patricio Santillán-Doherty, María del Rosario Flores-Soto, Luis Manuel Martínez-Barrera, Jerónimo Rafael Rodríguez-Cid, Carla Paola Sánchez-Ríos
  NCT Neumología y Cirugía de Tórax.2019; 78(4): 348.     CrossRef

Citations

Citations to this article as recorded by  

• Nasopharyngeal Carcinoma in Children, Current Treatment Approach
  Tal Ben-Ami
  Journal of Pediatric Hematology/Oncology.2024; 46(3): 117.     CrossRef
• Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study
  Ya-Nan Jin, Zhao-Hui Ruan, Wan-Wei Cao, Lin Yang, Wei Yao, Xiao-Feng Pei, Wang-Jian Zhang, Tia Marks, Ji-Jin Yao, Liang-Ping Xia
  Journal of Cancer Research and Clinical Oncology.2023; 149(13): 11929.     CrossRef
• Epidemiology and treatment of head and neck malignancies in the AYA generation
  Takahiro Asakage
  International Journal of Clinical Oncology.2022; 27(3): 465.     CrossRef
• Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020
  Yu-Jing Liang, Li-Ting Liu, Yang Li, Pan Wang, Mei-Juan Luo, Dong-Xiang Wen, Qiu-Yan Chen, Hai-Qiang Mai
  JAMA Network Open.2022; 5(3): e220173.     CrossRef
• LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis
  Tao Xie, Kunpeng Du, Wei Liu, Chunshan Liu, Baiyao Wang, Yunhong Tian, Rong Li, Xiaoting Huang, Jie Lin, Haifeng Jian, Jian Zhang, Yawei Yuan
  British Journal of Cancer.2022; 127(7): 1239.     CrossRef
• Exploring the Optimal Chemotherapy Strategy for Locoregionally Advanced Children and Adolescent Nasopharyngeal Carcinoma Based on Pretreatment Epstein-Barr Virus DNA Level in the Era of Intensity Modulated Radiotherapy
  Ziyi Zeng, Chen Chen, Lanlan Guo, Cheng Zhang, Lei Chen, Chuanping Yuan, Lixia Lu
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study
  Ya-Nan Jin, Ji-Jin Yao, Ya-Fei You, Hui-Jiao Cao, Zi-Zi Li, Dan-Ling Dai, Wang-Jian Zhang, Tia Marks, Bei Zhang, Liang-Ping Xia
  Radiotherapy and Oncology.2021; 161: 83.     CrossRef
• Nasopharyngeal carcinoma in children: Multimodal treatment and long‐term outcome of 92 patients in a single center over a 28‐year period
  Rejin Kebudi, Sema Bay Buyukkapu, Omer Gorgun, Kübra Ozkaya, Rasim Meral, Inci Ayan, Musa Altun
  Pediatric Blood & Cancer.2021;[Epub]     CrossRef
• Induction or adjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in paediatric nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA
  Yu-Jing Liang, Dong-Xiang Wen, Mei-Juan Luo, Lin-Quan Tang, Shan-Shan Guo, Pan Wang, Qiu-Yan Chen, Li-Ting Liu, Hai-Qiang Mai
  European Journal of Cancer.2021; 159: 133.     CrossRef
• Time-to-Event Supervised Genetic Algorithm Enables Induction Chemotherapy Decision Making for Nasopharyngeal Carcinoma
  Demin Liu, Haojiang Li, Liyang Wu, Shuchao Chen, Tianqiao Zhang, Wenjie Huang, Guangying Ruan, Sai Li, Lizhi Liu, Hongbo Chen
  IEEE Access.2021; 9: 98701.     CrossRef
• LHX2 Facilitates the Progression of Nasopharyngeal Carcinoma via Activation of the FGF1/FGFR Axis
  Tao Xie, Kunpeng Du, Wei Liu, Chunshan Liu, Baiyao Wang, Yunhong Tian, Rong Li, Xiaoting Huang, Jie Lin, Haifeng Jian, Jian Zhang, Yawei Yuan
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• Prognostic impact of immunohistopathologic features in definitive radiation therapy for nasopharyngeal cancer patients
  Naoya Murakami, Taisuke Mori, Yuko Kubo, Seiichi Yoshimoto, Kimiteru Ito, Yoshitaka Honma, Takao Ueno, Kenya Kobayashi, Hiroyuki Okamoto, Narikazu Boku, Kana Takahashi, Koji Inaba, Kae Okuma, Hiroshi Igaki, Yuko Nakayama, Jun Itami
  Journal of Radiation Research.2020; 61(1): 161.     CrossRef
• The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis
  Bi-Cheng Wang, Bo-Ya Xiao, Guo-He Lin, Chang Wang, Quentin Liu
  BMC Cancer.2020;[Epub]     CrossRef
• Update in pediatric nasopharyngeal undifferentiated carcinoma
  Line Claude, Emmanuel Jouglar, Loig Duverge, Daniel Orbach
  The British Journal of Radiology.2019;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Breast conserving surgery combined with radiation therapy offers improved survival over mastectomy in early-stage breast cancer
  Elizaveta Vasilyeva, Alan Nichol, Brendan Bakos, Anise Barton, Michelle Goecke, Elaine Lam, Erin Martin, Caroline Lohrisch, Elaine McKevitt
  The American Journal of Surgery.2024; 231: 70.     CrossRef
• Oncoplastic Breast Conservation for Central Tumors: Definition, Classification, and the Analysis of Single Institution Experience
  Andrii Zhygulin, Artem Fedosov
  Plastic and Reconstructive Surgery - Global Open.2024; 12(5): e5789.     CrossRef
• Treatment Outcomes after Postoperative Radiotherapy in Triple-Negative Breast Cancer: Multi-Institutional Retrospective Study (KROG 17-05)
  Jin Kim, Sang Byun, Myeongsoo Kim, Kyung Shin, Dong Kim, Han Lee, Tae Kim, Yeon Kim, Yong Kim, Jee Chang, Kyubo Kim, Sun Lee
  Journal of Personalized Medicine.2024; 14(9): 941.     CrossRef
• Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
  Rajesh Pradhan, Anuradha Dey, Rajeev Taliyan, Anu Puri, Sanskruti Kharavtekar, Sunil Kumar Dubey
  Pharmaceutics.2023; 15(1): 246.     CrossRef
• Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients
  Elizaveta Vasilyeva, Jeremy Hamm, Alan Nichol, Kathryn V. Isaac, Amy Bazzarelli, Carl Brown, Caroline Lohrisch, Elaine McKevitt
  Annals of Surgical Oncology.2023; 30(11): 6413.     CrossRef
• Postmastectomy Radiation Therapy in Patients With Minimally Involved Lymph Nodes: A Review of the Current Data and Future Directions
  Bum-Sup Jang, Kyung Hwan Shin
  Journal of Breast Cancer.2022; 25(1): 1.     CrossRef
• A Review of Current treatment for Triple-Negative Breast Cancer (TNBC)
  Wahyuni Wahyuni, Ajeng Diantini, Mohammad Ghozali, Sahidin I
  Research Journal of Pharmacy and Technology.2022; : 409.     CrossRef
• Long non-coding RNA MRPS30 divergent transcript can be detected in the cytoplasm of triple-negative breast cancer cells and is targeted by microRNA-130b
  Dongtao Wang, Qiang Song, Tianyong Zhao, Fang Wang, Yang Yu, Jing Qi, Pengfei Lyu, Xiangyang Duan
  Bioengineered.2022; 13(3): 5954.     CrossRef
• Breast-conserving surgery versus mastectomy for older women with triple-negative breast cancer: population-based study
  Waruiru Mburu, Shalini Kulasingam, James S Hodges, Beth A Virnig
  Journal of Comparative Effectiveness Research.2022; 11(13): 953.     CrossRef
• Determining prognostic factors and optimal surgical intervention for early-onset triple-negative breast cancer
  Yi-Zi Zheng, Yan Liu, Zhen-Han Deng, Guo-Wen Liu, Ni Xie
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy
  Chu-Ying Chen, Si-Yue Zheng, Gang Cai, Cheng Xu, Rong Cai, Min Li, Kun-Wei Shen, Xiao-Song Chen, Dan Ou, Wei-Xiang Qi, Lu Cao, Jia-Yi Chen, Weiren Luo
  Journal of Oncology.2022; 2022: 1.     CrossRef
• Значення локорегіонарної терапії у хворих на тричі негативний рак грудної залози (огляд літератури)
  M.V. Pavlushenko, R.V. Liubota, R.I. Vereshchako, O.S. Zotov, M.F. Anikusko, I.I. Liubota
  Practical oncology.2022; 5(1): 23.     CrossRef
• Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer
  Rebekah Macfie, Cynthia Aks, Kathryn Panwala, Nathalie Johnson, Jennifer Garreau
  The American Journal of Surgery.2021; 221(4): 809.     CrossRef
• Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: meta-analysis
  A Fancellu, N Houssami, V Sanna, A Porcu, C Ninniri, M L Marinovich
  British Journal of Surgery.2021; 108(7): 760.     CrossRef
• Are the Outcomes of Breast Conservation Surgery Inferior to Those of Mastectomy in Patients with Stage II-IIIA Triple-Negative Breast Cancer?
  Seungju Lee, Hyun Yul Kim, Youn Joo Jung, Hyun-June Paik, Dong-Il Kim, Chang Shin Jung, Seok-Kyung Kang, Jee Yeon Kim, Seokwon Lee, Youngtae Bae
  Journal of Breast Disease.2021; 9(2): 77.     CrossRef
• Thrombin generation predicts early recurrence in breast cancer patients
  Marina Marchetti, Cinzia Giaccherini, Giovanna Masci, Cristina Verzeroli, Laura Russo, Luigi Celio, Roberta Sarmiento, Sara Gamba, Carmen J. Tartari, Erika Diani, Alfonso Vignoli, Paolo Malighetti, Daniele Spinelli, Nicole M. Kuderer, Federico Nichetti, M
  Journal of Thrombosis and Haemostasis.2020; 18(9): 2220.     CrossRef
• Molecular Investigation on a Triple Negative Breast Cancer Xenograft Model Exposed to Proton Beams
  Francesco P. Cammarata, Giusi I. Forte, Giuseppe Broggi, Valentina Bravatà, Luigi Minafra, Pietro Pisciotta, Marco Calvaruso, Roberta Tringali, Barbara Tomasello, Filippo Torrisi, Giada Petringa, Giuseppe A. P. Cirrone, Giacomo Cuttone, Rosaria Acquaviva,
  International Journal of Molecular Sciences.2020; 21(17): 6337.     CrossRef
• Radiotherapy plays an important role in improving the survival outcome in patients with T1–2N1M0 breast cancer – a joint analysis of 4262 real world cases from two institutions
  Guang-Yi Sun, Ge Wen, Yu-Jing Zhang, Yu Tang, Hao Jing, Jian-Yang Wang, Jiang-Hu Zhang, Yong Yang, Xu-Ran Zhao, Si-Ye Chen, Jing Jin, Yong-Wen Song, Yue-Ping Liu, Hui Fang, Hua Ren, Yuan Tang, Shu-Nan Qi, Ning Li, Bo Chen, Ning-Ning Lu, Shu-Lian Wang, Ye-
  BMC Cancer.2020;[Epub]     CrossRef
• Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases
  Stefanie Corradini, Daniel Reitz, Montserrat Pazos, Stephan Schönecker, Michael Braun, Nadia Harbeck, Christiane Matuschek, Edwin Bölke, Ute Ganswindt, Filippo Alongi, Maximilian Niyazi, Claus Belka
  Cancers.2019; 11(2): 160.     CrossRef
• Are breast conservation treatment rates optimized for Asian women with symptomatic malignancies?
  Mona P. C. Tan, Yih Yiow Sitoh
  ANZ Journal of Surgery.2019; 89(5): 529.     CrossRef

Citations

Citations to this article as recorded by  

• A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study
  Hui-Jen Tsai, Shih-Hung Yang, Chin-Fu Hsiao, Hsiang-Fong Kao, Yung-Yeh Su, Yan-Shen Shan, Chia-Jui Yen, Jeng-Shiun Du, Chiun Hsu, I-Chen Wu, Li-Tzong Chen
  The Oncologist.2024; 29(10): e1396.     CrossRef
• Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study
  Hyehyun Jeong, Bum Jun Kim, Choong-kun Lee, Inkeun Park, Dae Young Zang, Hye Jin Choi, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dongwook Oh, Sung-Hoon Moon, Kyu-pyo Kim, Zev Wainberg, Baek-Yeol Ryoo, Changhoon Yoo
  European Journal of Cancer.2024; 208: 114194.     CrossRef
• Redox-responsive engineered hybrid nanomedicine for gallbladder cancer therapy via hyaluronic acid depletion
  Jinglin Zou, Cong Jiang, Xianglong Li, Tianyu Zhong, Shuqi Wang, Bo Wang, Dapeng Zhang, Ji-Na Hao, Yuanyuan Cao, Mengjia Guan, Peng Zhang, Bin Dai, Yongsheng Li
  Applied Materials Today.2023; 30: 101707.     CrossRef
• Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective
  Cindy Neuzillet, Pascal Artru, Eric Assenat, Julien Edeline, Xavier Adhoute, Jean-Christophe Sabourin, Anthony Turpin, Romain Coriat, David Malka
  Targeted Oncology.2023; 18(1): 51.     CrossRef
• Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis
  Junya Toyoda, Kota Sahara, Tomoaki Takahashi, Kentaro Miyake, Yasuhiro Yabushita, Yu Sawada, Yuki Homma, Ryusei Matsuyama, Itaru Endo, Timothy Pawlik
  Journal of Clinical Medicine.2023; 12(7): 2654.     CrossRef
• Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study
  Jean marc Phelip, Jérôme Desrame, Julien Edeline, Emilie Barbier, Eric Terrebonne, Pierre Michel, Hervé Perrier, Laetitia Dahan, Vincent Bourgeois, Faiza Khemissa Akouz, Emilie Soularue, Valérie Lebrun Ly, Yann Molin, Thierry Lecomte, François Ghiringhell
  Journal of Clinical Oncology.2022; 40(3): 262.     CrossRef
• Early Recurrence in Resected Gallbladder Carcinoma: Clinical Impact and Its Preoperative Predictive Score
  Yuji Shimizu, Ryo Ashida, Teiichi Sugiura, Yukiyasu Okamura, Katsuhisa Ohgi, Mihoko Yamada, Shimpei Otsuka, Takeshi Aramaki, Akifumi Notsu, Katsuhiko Uesaka
  Annals of Surgical Oncology.2022; 29(9): 5447.     CrossRef
• Efficacy and safety of modified FOLFIRINOX as salvage therapy for patients with refractory advanced biliary tract cancer: a retrospective study
  Liu-Fang Ye, Chao Ren, Long Bai, Jie-Ying Liang, Ming-Tao Hu, Hui Yang, Zhi-Qiang Wang, Feng-Hua Wang, Rui-Hua Xu, Yu-Hong Li, De-Shen Wang
  Investigational New Drugs.2021; 39(3): 836.     CrossRef
• Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
  Changhoon Yoo, Sang Hyun Shin, Joon-Oh Park, Kyu-Pyo Kim, Jae Ho Jeong, Baek-Yeol Ryoo, Woohyung Lee, Ki-Byung Song, Dae-Wook Hwang, Jin-hong Park, Jae Hoon Lee
  Cancers.2021; 13(7): 1647.     CrossRef
• Chemotherapy for advanced gallbladder cancer (GBC): A systematic review and meta-analysis
  Alexander A. Azizi, Angela Lamarca, Mairéad G. McNamara, Juan W. Valle
  Critical Reviews in Oncology/Hematology.2021; 163: 103328.     CrossRef
• Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative study
  Lu Zou, Xuechuan Li, Xiangsong Wu, Jiujie Cui, Xuya Cui, Xiaoling Song, Tai Ren, Xusheng Han, Yidi Zhu, Huaifeng Li, Wenguang Wu, Xu’an Wang, Wei Gong, Liwei Wang, Maolan Li, Wan Yee Lau, Yingbin Liu
  BMC Cancer.2021;[Epub]     CrossRef
• A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study
  Sung-Nan Pei, Chun-Kai Liao, Yaw-Sen Chen, Cheng-Hao Tseng, Chao-Ming Hung, Chong-Chi Chiu, Meng-Che Hsieh, Yu-Fen Tsai, Hsiu-Yun Liao, Wei-Ching Liu, Kun-Ming Rau
  Cancers.2021; 13(15): 3831.     CrossRef
• Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study
  Changhoon Yoo, Kyu-pyo Kim, Jae Ho Jeong, Ilhwan Kim, Myoung Joo Kang, Jaekyung Cheon, Byung Woog Kang, Hyewon Ryu, Ji Sung Lee, Kyung Won Kim, Ghassan K Abou-Alfa, Baek-Yeol Ryoo
  The Lancet Oncology.2021; 22(11): 1560.     CrossRef
• Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial
  Ali Belkouz, Judith de Vos-Geelen, Ron A. A. Mathôt, Ferry A. L. M. Eskens, Thomas M. van Gulik, Martijn G. H. van Oijen, Cornelis J. A. Punt, Johanna W. Wilmink, Heinz-Josef Klümpen
  British Journal of Cancer.2020; 122(5): 634.     CrossRef
• miR‐373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1
  Pin Lv, Yi‐Fan Luo, Wen‐Yi Zhou, Ben Liu, Zheng Zhou, Yong‐Zhong Shi, Ren Huang, Chuang Peng, Zi‐Li He, Jun Wang, Hong‐Hui Zhang, Sheng‐Dan Nie
  The Kaohsiung Journal of Medical Sciences.2020; 36(6): 429.     CrossRef
• Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials
  A. Belkouz, J.W. Wilmink, N. Haj Mohammad, J. Hagendoorn, J. de Vos-Geelen, C.H.C. Dejong, M.Y.V. Homs, B. Groot Koerkamp, T.M. van Gulik, M.G.H. van Oijen, C.J.A. Punt, H. Klümpen
  Critical Reviews in Oncology/Hematology.2020; 151: 102975.     CrossRef
• A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer
  Ayhan Ulusakarya, Abdoulaye Karaboué, Oriana Ciacio, Gabriella Pittau, Mazen Haydar, Pamela Biondani, Yusuf Gumus, Amale Chebib, Wathek Almohamad, Pasquale F. Innominato
  BMC Cancer.2020;[Epub]     CrossRef
• Overview of current targeted therapy in gallbladder cancer
  Xiaoling Song, Yunping Hu, Yongsheng Li, Rong Shao, Fatao Liu, Yingbin Liu
  Signal Transduction and Targeted Therapy.2020;[Epub]     CrossRef
• Irinotecan combined with oxaliplatin and S-1 in patients with metastatic pancreatic adenocarcinoma: a single-arm, three-centre, prospective study
  Keke Nie, Ling Zhang, Yunhong You, Hongmei Li, Xiuhui Guo, Zhongfa Zhang, Chunling Zhang, Youxin Ji
  Therapeutic Advances in Medical Oncology.2020;[Epub]     CrossRef
• The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: A meta-analysis and systematic review
  Ming-Liang Wang, Zhang-Yan Ke, Shuai Yin, Chen-Hai Liu, Qiang Huang
  Hepatobiliary & Pancreatic Diseases International.2019; 18(2): 110.     CrossRef
• Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
  L. Perkhofer, A. W. Berger, A. K. Beutel, E. Gallmeier, S. Angermeier, L. Fischer von Weikersthal, T. O. Goetze, R. Muche, T. Seufferlein, T. J. Ettrich
  BMC Cancer.2019;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Survival Impact of Combined Biguanide and Temozolomide in Glioblastoma Preclinical Models: A Systematic Review and Meta-Analysis
  Marcio Yuri Ferreira, Eloísa Bittencurt Thomaz de Assis, Savio Batista, Lucca B. Palavani, Gabriel Verly, Eduardo Mendes Corrêa, Lucas Pari Mitre, Jessica Sales de Oliveira, Raphael Bertani, Daniel Antunes Moreno, Allan Dias Polverini
  World Neurosurgery.2024; 183: 239.     CrossRef
• Metabolic Contrasts: Fatty Acid Oxidation and Ketone Bodies in Healthy Brains vs. Glioblastoma Multiforme
  Corina Tamas, Flaviu Tamas, Attila Kovecsi, Alina Cehan, Adrian Balasa
  International Journal of Molecular Sciences.2024; 25(10): 5482.     CrossRef
• Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma
  Melika Hajimohammadebrahim-Ketabforoush, Alireza Zali, Mohammadreza Shahmohammadi, Amir Ali Hamidieh
  Frontiers in Oncology.2024;[Epub]     CrossRef
• GBM Cells Exhibit Susceptibility to Metformin Treatment According to TLR4 Pathway Activation and Metabolic and Antioxidant Status
  Isabele Fattori Moretti, Antonio Marcondes Lerario, Paula Rodrigues Sola, Janaína Macedo-da-Silva, Mauricio da Silva Baptista, Giuseppe Palmisano, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie
  Cancers.2023; 15(3): 587.     CrossRef
• Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells
  Corinna Seliger, Lisa Rauer, Anne-Louise Wüster, Sylvia Moeckel, Verena Leidgens, Birgit Jachnik, Laura-Marie Ammer, Simon Heckscher, Katja Dettmer, Markus Riemenschneider, Peter Oefner, Martin Proescholdt, Arabel Vollmann-Zwerenz, Peter Hau
  International Journal of Molecular Sciences.2023; 24(4): 3199.     CrossRef
• The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme
  Mehdi Sanati, Samaneh Aminyavari, Hamid Mollazadeh, Ali Motamed-Sanaye, Bahram Bibak, Elmira Mohtashami, Yong Teng, Amir R. Afshari, Amirhossein Sahebkar
  Current Medicinal Chemistry.2023; 30(7): 857.     CrossRef
• Development and validation of a GC-MS method for determination of metformin in normal brain and in glioblastoma tissues
  Giorgia Ailuno, Sara Baldassari, Alice Balboni, Giuliana Drava, Cristina Spalletti, Elena Tantillo, Michele Mazzanti, Federica Barbieri, Stefano Thellung, Tullio Florio, Gabriele Caviglioli
  Journal of Pharmaceutical and Biomedical Analysis.2023; 234: 115503.     CrossRef
• Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
  Wan-Soo Yoon, Jong Hee Chang, Jeong Hoon Kim, Yu Jung Kim, Tae-Young Jung, Heon Yoo, Se-Hyuk Kim, Young-Cho Ko, Do-Hyun Nam, Tae Min Kim, Se Hoon Kim, Sung-Hae Park, Youn Soo Lee, Hyeon Woo Yim, Yong-Kil Hong, Seung Ho Yang
  Discover Oncology.2023;[Epub]     CrossRef
• Targeted c-Myc Inhibition and Systemic Temozolomide Therapy Extend Survival in Glioblastoma Xenografts
  Laxmi Dhungel, Cayla Harris, Lauren Romine, Jan Sarkaria, Drazen Raucher
  Bioengineering.2023; 10(6): 718.     CrossRef
• Could Metformin and Resveratrol Support Glioblastoma Treatment? A Mechanistic View at the Cellular Level
  Raghad Sabaawi Ibrahim, Shahad Sabaawi Ibrahim, Ahmed El-Naas, Lenka Koklesová, Peter Kubatka, Dietrich Büsselberg
  Cancers.2023; 15(13): 3368.     CrossRef
• Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities
  Tzu-Jen Kao, Chien-Liang Lin, Wen-Bin Yang, Hao-Yi Li, Tsung-I Hsu
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• THERAPEUTIC USE OF METFORMIN IN THYROID CANCER
  Fatimah Haitham Fathi, Ammar A. Y. Almulathanon, Jehan A. Mohammad
  Military Medical Science Letters.2022; 91(4): 348.     CrossRef
• Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment
  Haksoo Lee, Dahye Kim, BuHyun Youn
  International Journal of Molecular Sciences.2022; 23(22): 13818.     CrossRef
• Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway
  Jinbiao Xiong, Gaochao Guo, Lianmei Guo, Zengguang Wang, Zhijuan Chen, Yang Nan, Yiyao Cao, Ruilong Li, Xuejun Yang, Jun Dong, Xun Jin, Weidong Yang, Qiang Huang
  ACS Omega.2021; 6(6): 4289.     CrossRef
• Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma
  Silvia Valtorta, Alessia Lo Dico, Isabella Raccagni, Cristina Martelli, Valentina Pieri, Paolo Rainone, Sergio Todde, Bastian Zinnhardt, Elisabetta De Bernardi, Angela Coliva, Letterio S. Politi, Thomas Viel, Andreas H. Jacobs, Rossella Galli, Luisa Ottob
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Natural Compounds in Glioblastoma Therapy: Preclinical Insights, Mechanistic Pathways, and Outlook
  Kevin Zhai, Manaal Siddiqui, Basma Abdellatif, Alena Liskova, Peter Kubatka, Dietrich Büsselberg
  Cancers.2021; 13(10): 2317.     CrossRef
• Role of Polymeric Local Drug Delivery in Multimodal Treatment of Malignant Glioma: A Review
  Yuan-Yun Tseng, Tai-Yuan Chen, Shih-Jung Liu
  International Journal of Nanomedicine.2021; Volume 16: 4597.     CrossRef
• In Vitro and In Vivo Enhancement of Temozolomide Effect in Human Glioblastoma by Non-Invasive Application of Cold Atmospheric Plasma
  Vikas Soni, Manish Adhikari, Hayk Simonyan, Li Lin, Jonathan H. Sherman, Colin N. Young, Michael Keidar
  Cancers.2021; 13(17): 4485.     CrossRef
• Landscape of the oncogenic role of fatty acid synthase in human tumors
  Xulei Huo, Lairong Song, Da Li, Ke Wang, Yali Wang, Feng Chen, Liwei Zhang, Liang Wang, Junting Zhang, Zhen Wu
  Aging.2021; 13(23): 25106.     CrossRef
• Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer
  Sonia A. Allen, Sandipan Datta, Jose Sandoval, Alexey Tomilov, Thomas Sears, Kevin Woolard, James M. Angelastro, Gino A. Cortopassi
  Mitochondrion.2020; 50: 19.     CrossRef
• Metformin treatment decreases the expression of cancer stem cell marker CD44 and stemness related gene expression in primary oral cancer cells
  Shankargouda Patil
  Archives of Oral Biology.2020; 113: 104710.     CrossRef
• Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep- 2 to 5-Fluorouracil
  Neslisah Barlak, Fatma Sanli, Ozel Capik, Elanur Tuysuz, Elanur Aydın Karatas, Hasan Turkez, Omer Faruk Karatas
  Clinical Cancer Drugs.2020; 7(1): 16.     CrossRef
• An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin
  Marta Calvo Tardón, Eliana Marinari, Denis Migliorini, Viviane Bes, Stoyan Tankov, Emily Charrier, Thomas A McKee, Valérie Dutoit, Pierre-Yves Dietrich, Erika Cosset, Paul R Walker
  Biology.2020; 9(9): 264.     CrossRef
• Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
  Rashmi R. Shah, Peter D. Stonier
  Journal of Clinical Pharmacy and Therapeutics.2019; 44(1): 6.     CrossRef
• Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity
  Federica Barbieri, Ivan Verduci, Valentina Carlini, Gianluigi Zona, Aldo Pagano, Michele Mazzanti, Tullio Florio
  Frontiers in Oncology.2019;[Epub]     CrossRef
• DrugR+: A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy
  Yosef Masoudi-Sobhanzadeh, Yadollah Omidi, Massoud Amanlou, Ali Masoudi-Nejad
  Computers in Biology and Medicine.2019; 109: 254.     CrossRef
• Role of Metformin and AKT Axis Modulation in the Reversion of Hypoxia Induced TMZ-Resistance in Glioma Cells
  Alessia Lo Dico, Silvia Valtorta, Luisa Ottobrini, Rosa Maria Moresco
  Frontiers in Oncology.2019;[Epub]     CrossRef
• Repurposing drugs for the treatment of glioma
  Chengming Xu, Yaodong Zhao, Congyan Wu, Lei Li
  Glioma.2019; 2(4): 159.     CrossRef
• Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway
  Chung-Ching Chio, Yu-Ting Tai, Mahendravarman Mohanraj, Shing-Hwa Liu, Shun-Tai Yang, Ruei-Ming Chen
  Phytomedicine.2018; 49: 41.     CrossRef
• Pleiotropic Effects of Metformin on Cancer
  Hans-Juergen Schulten
  International Journal of Molecular Sciences.2018; 19(10): 2850.     CrossRef
• Metformin attenuates cells stemness and epithelial‑mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/β‑catenin pathway
  Chu Zhang, Yuchen Wang
  Molecular Medicine Reports.2018;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Impact of Smoking and Alcohol Consumption on Early-Onset Gastric Cancer Development in Young Koreans: A Population-Based Study
  Seung Joo Kang, Cheol Min Shin, Kyungdo Han, Jin Hyung Jung, Eun Hyo Jin, Joo Hyun Lim, Yoon Jin Choi, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee
  Journal of Gastric Cancer.2024; 24(2): 145.     CrossRef
• Population‐based evaluation of disparities in stomach cancer by nativity among Asian and Hispanic populations in California, 2011–2015
  Eunjung Lee, Kai‐Ya Tsai, Juanjuan Zhang, Amie E. Hwang, Dennis Deapen, Jennifer J. Koh, Eric S. Kawaguchi, James Buxbaum, Sang Hoon Ahn, Lihua Liu
  Cancer.2024; 130(7): 1092.     CrossRef
• Autoimmune conditions and gastric cancer risk in a population-based study in the United Kingdom
  John D. Murphy, Shahinaz M. Gadalla, Lesley A. Anderson, Charles S. Rabkin, Chris R. Cardwell, Minkyo Song, M. Constanza Camargo
  British Journal of Cancer.2024; 131(1): 138.     CrossRef
• Long-Term Outcome of Proximal Gastrectomy for Upper-Third Advanced Gastric and Siewert Type II Esophagogastric Junction Cancer Compared With Total Gastrectomy: A Propensity Score-Matched Analysis
  Seungho Lee, Yoon Soo Chae, Won-Gun Yun, Jane Chungyoon Kim, Jae Kyun Park, Min Gyu Kim, Jeesun Kim, Yo-Seok Cho, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Han-Kwang Yang
  Annals of Surgical Oncology.2024; 31(5): 3024.     CrossRef
• Risk prediction model for gastric cancer within 5 years in healthy Korean adults
  Hyungseok Oh, Sunwoo Cho, Jung Ah Lee, Seungho Ryu, Yoosoo Chang
  Gastric Cancer.2024; 27(4): 675.     CrossRef
• Gastric neuroendocrine neoplasms
  Giuseppe Lamberti, Francesco Panzuto, Marianne Pavel, Dermot O’Toole, Valentina Ambrosini, Massimo Falconi, Rocio Garcia-Carbonero, Rachel P. Riechelmann, Guido Rindi, Davide Campana
  Nature Reviews Disease Primers.2024;[Epub]     CrossRef
• Comparing global trends in gastric cancer and the need for national screening programs: An in-depth literature review
  Aditya Mavinkurve, Mahul Patel, Amanda Shabana, Teesta Das
  Open Health.2024;[Epub]     CrossRef
• Increasing disparities in the proportions of active treatment and 5-year overall survival over time by age groups among older patients with gastric cancer in Korea
  Hyun-Soo Zhang, Dong-Woo Choi, Han Sang Kim, Hye Jung Kang, Hoyol Jhang, Wonjeong Jeong, Chung Mo Nam, Sohee Park
  Frontiers in Public Health.2023;[Epub]     CrossRef
• Risk of Gastric Cancer among Patients with Newly Diagnosed Ulcerative Colitis: A Nationwide Population-Based Study
  Hee Man Kim, Jihoon Kim, Hyunil Kim, Soon Chang Park, Jung Kuk Lee, Dae Ryong Kang, Su Young Kim, Hyun-Soo Kim
  Journal of Clinical Medicine.2023; 12(8): 2843.     CrossRef
• Efficacy of Lymph Node Location-Number Hybrid Staging System on the Prognosis of Gastric Cancer Patients
  Junpeng Wu, Hao Wang, Xin Yin, Xibo Wang, Yufei Wang, Zhanfei Lu, Jiaqi Zhang, Yao Zhang, Yingwei Xue
  Cancers.2023; 15(9): 2659.     CrossRef
• Genomic differentiation within East Asian Helicobacter pylori
  Yuanhai You, Kaisa Thorell, Lihua He, Koji Yahara, Yoshio Yamaoka, Jeong-Heon Cha, Kazunari Murakami, Yukako Katsura, Ichizo Kobayashi, Daniel Falush, Jianzhong Zhang
  Microbial Genomics .2022;[Epub]     CrossRef
• Development and external validation of a nomogram for individualized adjuvant imatinib duration for high‐risk gastrointestinal stromal tumors: A multicenter retrospective cohort study
  Ruolin Liu, Yingxin Wu, Jin Gong, Rui Zhao, Li Li, Qianyi Wan, Nan Lian, Xiaoding Shen, Lin Xia, Yuhou Shen, Haitao Xiao, Xiaoting Wu, Yi Chen, Ying Cen, Xuewen Xu
  Cancer Medicine.2022; 11(16): 3093.     CrossRef
• 20-Year Trends in Detection Rates of Cardia Cancer via Endoscopic Surveillance in Tianjin, China: A Hospital-Based Study
  Rui Wang, Xiaowei Wu, Yan Song, Rui Lin, Zhongqing Zheng, Kui Jiang, Wentian Liu, Min Tang
  Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
• Declining trends of prevalence ofHelicobacter pyloriinfection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis
  Mei‐Jyh Chen, Ming‐Jong Bair, Po‐Yueh Chen, Ji‐Yuh Lee, Tsung‐Hua Yang, Yu‐Jen Fang, Chieh‐Chang Chen, An‐Ti Chang, Wang‐De Hsiao, Jian‐Jyun Yu, Chia‐Chi Kuo, Min‐Chin Chiu, Kun‐Pei Lin, Min‐Horn Tsai, Yao‐Chun Hsu, Chu‐Kuang Chou, Chi‐Yi Chen, Jaw‐Town L
  Helicobacter.2022;[Epub]     CrossRef
• Epidemiology of Gastric Cancer in Korea: Trends in Incidence and Survival Based on Korea Central Cancer Registry Data (1999–2019)
  Sin Hye Park, Mee Joo Kang, E Hwa Yun, Kyu-Won Jung
  Journal of Gastric Cancer.2022; 22(3): 160.     CrossRef
• Decreasing Incidence of Gastric Cancer with Increasing Time after Helicobacter pylori Treatment: A Nationwide Population-Based Cohort Study
  Taewan Kim, Seung In Seo, Kyung Joo Lee, Chan Hyuk Park, Tae Jun Kim, Jinseob Kim, Woon Geon Shin
  Antibiotics.2022; 11(8): 1052.     CrossRef
• Clinicopathological difference between gastric cancer in the lesser curvature and gastric cancer in the greater curvature
  Guo-Cai Li, Hong-Wei Zhang, Hong-Gang Tian, Yun Zhao, Qin-Xian Huang, Ze-Yu Xu, Xiao-Hui Xi, Kai Zhang
  Medicine.2022; 101(33): e29984.     CrossRef
• Impact of Cardiovascular Diseases on Mortality in Gastric Cancer Patients with Preexisting Chronic Disease
  Kyu-Tae Han, Dong Wook Kim, Woorim Kim
  Yonsei Medical Journal.2022; 63(11): 1043.     CrossRef
• Long‑term outcome of the endoscopic submucosal dissection of early gastric cancer: A comparison between patients with and without liver cirrhosis
  Seung Kim, Moon Joo, Ah-Young Yoo, Seong Kim, Won Kim, Beom Lee, Jong Park, Hoon Chun, Sang Lee
  Oncology Letters.2022;[Epub]     CrossRef
• International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk
  Benjamin Ascherman, Aaron Oh, Chin Hur
  Gastric Cancer.2021; 24(4): 878.     CrossRef
• Impact of Palliative Gastrectomy in Patients with Incurable Gastric Cancer
  Ji Yeon Park, Byunghyuk Yu, Ki Bum Park, Oh Kyoung Kwon, Seung Soo Lee, Ho Young Chung
  Medicina.2021; 57(3): 198.     CrossRef
• Clinical practice guideline for endoscopic resection of early gastrointestinal cancer
  Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong
  Intestinal Research.2021; 19(2): 127.     CrossRef
• Oncologic Feasibility of Proximal Gastrectomy in Upper Third Advanced Gastric and Esophagogastric Junctional Cancer
  Won-Gun Yun, Myung-Hoon Lim, Sarah Kim, Sa-Hong Kim, Ji-Hyeon Park, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Han-Kwang Yang
  Journal of Gastric Cancer.2021; 21(2): 169.     CrossRef
• Is Splenic Hilar Lymph Node Dissection Without Splenectomy Essential for Proximal Advanced Gastric Cancer?
  Yoon Jung Oh, Deok Hee Kim, Bang Wool Eom, Hong Man Yoon, Young-Woo Kim, Keun Won Ryu
  Annals of Surgical Oncology.2021; 28(13): 8952.     CrossRef
• Preferences of first-degree relatives of gastric cancer patients for gastric cancer screening: a discrete choice experiment
  Hui-qin Li, Hui Xue, Hua Yuan, Guang-ying Wan, Xiu-ying Zhang
  BMC Cancer.2021;[Epub]     CrossRef
• Restoration for the foregut surgery: bridging gaps between foregut surgery practice and academia
  Ye-lim Shin, Shin-Hoo Park, Yeongkeun Kwon, Chang Min Lee, Sungsoo Park
  Journal of Minimally Invasive Surgery.2021; 24(4): 175.     CrossRef
• Prevalence of Regional Lymph Node Metastasis of Mucosal Gastric Signet Ring Cell Carcinoma: Analysis of the Collaborative Stage Data Survey of the Korean Central Cancer Registry
  Seok-Hoo Jeong, Jin Woo Kim, Hee Man Kim
  Digestive Surgery.2021; 38(5-6): 330.     CrossRef
• Determining the current indications for endoscopic submucosal dissection in patients with Lauren mixed‐type early gastric cancer
  Jinju Choi, Hyunsoo Chung, Jung Kim, Jue Lie Kim, Sang Gyun Kim, Hyun Chae Jung
  Journal of Gastroenterology and Hepatology.2020; 35(4): 586.     CrossRef
• Effect of histologic differences between biopsy and final resection on treatment outcomes in early gastric cancer
  Yonsoo Kim, Hong Jin Yoon, Jie-Hyun Kim, Jaeyoung Chun, Young Hoon Youn, Hyojin Park, In Gyu Kwon, Seung Ho Choi, Sung Hoon Noh
  Surgical Endoscopy.2020; 34(11): 5046.     CrossRef
• Nationwide prevalence of potential drug-drug interactions associated with non-anticancer agents in patients on oral anticancer agents in South Korea
  Yun-Kyoung Song, Jung Mi Oh
  Supportive Care in Cancer.2020; 28(8): 3711.     CrossRef
• Long-term outcomes of patients with gastric adenoma in Korea
  Tae Young Park, Su Jin Jeong, Tae Hyung Kim, Jin Lee, Jongha Park, Tae Oh Kim, Yong Eun Park
  Medicine.2020; 99(12): e19553.     CrossRef
• Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer
  Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong
  Clinical Endoscopy.2020; 53(2): 142.     CrossRef
• Current status and trend in training for endoscopic submucosal dissection: A nationwide survey in Korea
  Jae Gon Lee, Chan Hyuk Park, Hyunsoo Chung, Jun Chul Park, Do Hoon Kim, Bo-In Lee, Jeong-Sik Byeon, Hwoon-Yong Jung, Richard Bruce Mink
  PLOS ONE.2020; 15(5): e0232691.     CrossRef
• The expression of epidermal growth factor receptor 1 and human epidermal growth factor receptor 2 based on tumor location affect survival in gastric cancer
  Guo-Cai Li, Xu-Chun Jia, Qing-Chuan Zhao, Hong-Wei Zhang, Peng Yang, Long-Long Xu, Fang-Ning Pang, Jian-Bing Sun
  Medicine.2020; 99(21): e20460.     CrossRef
• Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer
  Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong
  The Korean Journal of Gastroenterology.2020; 75(5): 264.     CrossRef
• Effects of p-coumaric acid on microRNA expression profiles in SNU-16 human gastric cancer cells
  Mi Gyeong Jang, Hee Chul Ko, Se-Jae Kim
  Genes & Genomics.2020; 42(7): 817.     CrossRef
• Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer
  Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2020; 20(2): 117.     CrossRef
• Vitamin D Status and Gastric Cancer: A Cross-Sectional Study in Koreans
  Jung Hyun Kwak, Jean Kyung Paik
  Nutrients.2020; 12(7): 2004.     CrossRef
• The loss of nuclear expression of single-stranded DNA binding protein 2 of gastric adenocarcinoma and its prognostic role: Analysis of molecular subtype
  Seongsik Bang, Hyunsung Kim, Kiseok Jang, Seung Sam Paik, Su-Jin Shin, Valli De Re
  PLOS ONE.2020; 15(8): e0236896.     CrossRef
• Changing trends of clinicopathologic features and survival duration after surgery for gastric cancer in Northeast China
  Zhao Zhai, Zi-Yu Zhu, Xi-Liang Cong, Bang-Ling Han, Jia-Liang Gao, Xin Yin, Yu Zhang, Sheng-Han Lou, Tian-Yi Fang, Yi-Min Wang, Chun-Feng Li, Xue-Feng Yu, Yan Ma, Ying-Wei Xue
  World Journal of Gastrointestinal Oncology.2020; 12(10): 1119.     CrossRef
• Endoscopic History and Provider Characteristics Influence Gastric Cancer Survival in Asian Americans
  Christie Y. Jeon, Yu-Chen Lin, Samuel J. Klempner, Bechien U. Wu, Sungjin Kim, Kevin M. Waters, Robert W. Haile
  Cancer Prevention Research.2020; 13(9): 773.     CrossRef
• Endoscopic Resection of Undifferentiated-type Early Gastric Cancer
  Ayoung Lee, Hyunsoo Chung
  Journal of Gastric Cancer.2020; 20(4): 345.     CrossRef
• Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells
  Sun Tae Hwang, Chulwon Kim, Jong Hyun Lee, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Omar H.M. Shair, Gautam Sethi, Kwang Seok Ahn
  Phytomedicine.2019; 59: 152907.     CrossRef
• Prospective Multicenter Feasibility Study of Laparoscopic Sentinel Basin Dissection after Endoscopic Submucosal Dissection for Early Gastric Cancer: SENORITA 2 Trial Protocol
  Bang Wool Eom, Hong Man Yoon, Jae Seok Min, In Cho, Ji-Ho Park, Mi Ran Jung, Hoon Hur, Young-Woo Kim, Young Kyu Park, Byung-Ho Nam, Keun Won Ryu
  Journal of Gastric Cancer.2019; 19(2): 157.     CrossRef
• Changes in the Clinical and Pathological Characteristics of Gastric Cancer during the Last 16 Years: A Study of a Single Institution in Korea
  Jung Won Lee, Nayoung Kim, Yong Jae Kwon, Hye Seung Lee
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2019; 19(2): 120.     CrossRef
• TRP channels in gastric cancer: New hopes and clinical perspectives
  Andra M. Sterea, Emmanuel E. Egom, Yassine El Hiani
  Cell Calcium.2019; 82: 102053.     CrossRef
• Autoimmune Diseases and Gastric Cancer Risk: A Systematic Review and Meta-Analysis
  Minkyo Song, Gonzalo Latorre, Danisa Ivanovic-Zuvic, M. Constanza Camargo, Charles S. Rabkin
  Cancer Research and Treatment.2019; 51(3): 841.     CrossRef
• Prognostic Value of Metabolic Information in Advanced Gastric Cancer Using Preoperative 18F-FDG PET/CT
  Hye Ryeong Kwon, Kisoo Pahk, Sungsoo Park, Hyun Woo Kwon, Sungeun Kim
  Nuclear Medicine and Molecular Imaging.2019; 53(6): 386.     CrossRef
• Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications
  Jiwon Koh, Keun-Wook Lee, Soo Kyung Nam, An Na Seo, Ji-Won Kim, Jin Won Kim, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
  The Oncologist.2019; 24(12): e1321.     CrossRef
• Gastric Cancer: an Evolving Disease
  Minkyo Song, Charles S. Rabkin, M. Constanza Camargo
  Current Treatment Options in Gastroenterology.2018; 16(4): 561.     CrossRef

Citations

Citations to this article as recorded by  

• Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer
  Harshabad Singh, Ashley Kang, Lisa Bloudek, Ling-I Hsu, Maria Corinna Palanca-Wessels, Michael Stecher, Muriel Siadak, Kimmie Ng
  JNCI Cancer Spectrum.2024;[Epub]     CrossRef
• Molecular characterization of colorectal mucinous adenocarcinoma and adenocarcinoma, not otherwise specified, identified by multiomic data analysis
  Kailun Xu, Shu Zheng, Baosheng Li, Yingkuan Shao, Xiaoyang Yin
  Frontiers in Molecular Biosciences.2023;[Epub]     CrossRef
• Mechanism of 5-fluorouracil nanoparticles on releasing skin squamous cell carcinoma through regulation of Wnt/β-catenin expression
  Lixin Peng, Xinping Zhang, Bin Du, Liangliang Sun, Yuguang Zhao
  Materials Express.2022; 12(2): 220.     CrossRef
• Research on Anti-Tumor Nano-Particle with New Type 5-Fluorouracil on the Peritoneal Metastasis of Breast Cancer
  Yujie Xiao, Guilin Huang, Yibo Xiang
  Journal of Biomaterials and Tissue Engineering.2021; 11(7): 1277.     CrossRef
• Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
  Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Remus Iulian Nica, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga
  International Journal of Molecular Sciences.2021; 22(19): 10260.     CrossRef
• SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF
  Weikai Xiao, Shaoquan Zheng, Xinhua Xie, Xing Li, Lijuan Zhang, Anli Yang, Jian Wang, Hailin Tang, Xiaoming Xie
  Molecular Therapy - Oncolytics.2020; 17: 118.     CrossRef

• Combined Therapeutic Effects of ¹³¹I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer

  
  Pingping Wu, Huayun Zhu, Yan Zhuang, Xiaofeng Sun, Ning Gu
  International Journal of Nanomedicine.2020; Volume 15: 2777.     CrossRef
• Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon
  Pingping Wu, Qing Zhou, Huayun Zhu, Yan Zhuang, Jun Bao
  BMC Cancer.2020;[Epub]     CrossRef
• HER4 promotes the progression of colorectal cancer by promoting epithelial‑mesenchymal transition
  Xiaojing Jia, Huien Wang, Zhongxin Li, Jing Yan, Yan Guo, Wujie Zhao, Lixia Gao, Bin Wang, Yitao Jia
  Molecular Medicine Reports.2020;[Epub]     CrossRef
• Epidermal Growth Factor Receptor: Key to Selective Intracellular Delivery
  A. A. Rosenkranz, T. A. Slastnikova
  Biochemistry (Moscow).2020; 85(9): 967.     CrossRef
• Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
  Said Abdullah Khelwatty, Sharadah Essapen, Izhar Bagwan, Margaret Green, Alan M. Seddon, Helmout Modjtahedi
  Oncotarget.2019; 10(18): 1704.     CrossRef